| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| MicroRNAs | 31 | 2019 | 1787 | 5.31 | Why? |
| Apoptosis | 70 | 2019 | 2335 | 4.76 | Why? |
| NF-kappa B | 33 | 2019 | 1301 | 3.93 | Why? |
| Gene Expression Regulation, Neoplastic | 35 | 2019 | 1014 | 3.48 | Why? |
| Liver Neoplasms | 22 | 2019 | 1666 | 3.34 | Why? |
| Cell Proliferation | 72 | 2019 | 1973 | 3.30 | Why? |
| Cell Line, Tumor | 73 | 2019 | 3608 | 3.14 | Why? |
| Carcinoma, Hepatocellular | 19 | 2019 | 1222 | 3.12 | Why? |
| Carcinoma, Non-Small-Cell Lung | 16 | 2019 | 896 | 3.08 | Why? |
| Tumor Suppressor Protein p53 | 9 | 2019 | 310 | 2.92 | Why? |
| Neoplasm Invasiveness | 23 | 2019 | 582 | 2.60 | Why? |
| Uterine Cervical Neoplasms | 9 | 2018 | 842 | 2.59 | Why? |
| Lung Neoplasms | 26 | 2019 | 3228 | 2.52 | Why? |
| Mice, Nude | 26 | 2019 | 340 | 2.52 | Why? |
| Biomarkers, Tumor | 21 | 2019 | 1314 | 2.47 | Why? |
| Antineoplastic Agents | 29 | 2019 | 3550 | 2.41 | Why? |
| Cell Movement | 30 | 2019 | 695 | 2.31 | Why? |
| Signal Transduction | 61 | 2019 | 7207 | 2.29 | Why? |
| Animals | 230 | 2020 | 78931 | 2.25 | Why? |
| Mice | 126 | 2020 | 21357 | 2.25 | Why? |
| Osteosarcoma | 4 | 2018 | 83 | 2.13 | Why? |
| NF-E2-Related Factor 2 | 9 | 2019 | 373 | 2.12 | Why? |
| Neurons | 10 | 2018 | 864 | 2.05 | Why? |
| p38 Mitogen-Activated Protein Kinases | 7 | 2018 | 230 | 2.02 | Why? |
| Repressor Proteins | 5 | 2018 | 232 | 2.01 | Why? |
| Transforming Growth Factor beta1 | 4 | 2018 | 204 | 2.00 | Why? |
| Diabetes Mellitus, Experimental | 8 | 2019 | 192 | 2.00 | Why? |
| Myelodysplastic Syndromes | 5 | 2019 | 261 | 1.99 | Why? |
| Xenograft Model Antitumor Assays | 21 | 2019 | 274 | 1.99 | Why? |
| Rats | 44 | 2019 | 2764 | 1.99 | Why? |
| Epithelial-Mesenchymal Transition | 12 | 2019 | 242 | 1.99 | Why? |
| Nanoparticles | 13 | 2018 | 2040 | 1.98 | Why? |
| Cell Differentiation | 16 | 2019 | 1338 | 1.92 | Why? |
| ErbB Receptors | 11 | 2018 | 320 | 1.92 | Why? |
| Bipolar Disorder | 5 | 2018 | 744 | 1.90 | Why? |
| RNA, Small Interfering | 22 | 2019 | 817 | 1.89 | Why? |
| Reactive Oxygen Species | 15 | 2019 | 1136 | 1.88 | Why? |
| MAP Kinase Signaling System | 12 | 2019 | 360 | 1.78 | Why? |
| Osteoclasts | 4 | 2019 | 67 | 1.73 | Why? |
| Islets of Langerhans | 3 | 2018 | 138 | 1.72 | Why? |
| RNA, Long Noncoding | 8 | 2019 | 408 | 1.70 | Why? |
| Stomach Neoplasms | 10 | 2018 | 477 | 1.69 | Why? |
| Lymphatic Metastasis | 12 | 2019 | 537 | 1.65 | Why? |
| Granulosa Cells | 4 | 2018 | 13 | 1.64 | Why? |
| Macrophages | 14 | 2019 | 2784 | 1.64 | Why? |
| DNA Damage | 6 | 2019 | 285 | 1.61 | Why? |
| Leukemia, Myelomonocytic, Chronic | 3 | 2018 | 37 | 1.61 | Why? |
| Breast Neoplasms | 18 | 2019 | 3633 | 1.60 | Why? |
| Bone Neoplasms | 3 | 2018 | 287 | 1.60 | Why? |
| Leukemia, Erythroblastic, Acute | 3 | 2017 | 5 | 1.60 | Why? |
| Neuroprotective Agents | 10 | 2018 | 240 | 1.57 | Why? |
| Autophagy | 13 | 2019 | 960 | 1.57 | Why? |
| Hyaluronan Receptors | 3 | 2017 | 61 | 1.53 | Why? |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2018 | 82 | 1.52 | Why? |
| Protein Kinase Inhibitors | 14 | 2019 | 1585 | 1.52 | Why? |
| Rats, Sprague-Dawley | 27 | 2019 | 987 | 1.47 | Why? |
| Liquid Biopsy | 2 | 2019 | 114 | 1.46 | Why? |
| Down-Regulation | 14 | 2019 | 1416 | 1.45 | Why? |
| Phenanthrenes | 2 | 2018 | 87 | 1.44 | Why? |
| Blinking | 2 | 2017 | 11 | 1.44 | Why? |
| Gene Expression Regulation | 26 | 2019 | 4020 | 1.43 | Why? |
| RNA, Neoplasm | 2 | 2018 | 34 | 1.42 | Why? |
| Lipoproteins, HDL | 3 | 2018 | 154 | 1.41 | Why? |
| Gastrointestinal Stromal Tumors | 3 | 2019 | 84 | 1.41 | Why? |
| Cell Separation | 4 | 2019 | 270 | 1.40 | Why? |
| Ferric Compounds | 3 | 2017 | 136 | 1.38 | Why? |
| Genetic Therapy | 5 | 2018 | 409 | 1.36 | Why? |
| Polymorphism, Single Nucleotide | 10 | 2018 | 3607 | 1.35 | Why? |
| Cell Hypoxia | 6 | 2018 | 141 | 1.35 | Why? |
| Neovascularization, Pathologic | 8 | 2019 | 305 | 1.34 | Why? |
| Antioxidants | 9 | 2019 | 1593 | 1.32 | Why? |
| Neural Pathways | 3 | 2017 | 155 | 1.32 | Why? |
| Insecticides | 2 | 2018 | 178 | 1.32 | Why? |
| Human Umbilical Vein Endothelial Cells | 9 | 2019 | 286 | 1.31 | Why? |
| Magnetic Resonance Imaging | 19 | 2020 | 6551 | 1.29 | Why? |
| Tumor Microenvironment | 2 | 2018 | 264 | 1.26 | Why? |
| Janus Kinase 2 | 2 | 2019 | 218 | 1.26 | Why? |
| Hippocampus | 7 | 2018 | 237 | 1.26 | Why? |
| Insulin-Secreting Cells | 3 | 2017 | 273 | 1.26 | Why? |
| Microfluidic Analytical Techniques | 3 | 2017 | 254 | 1.25 | Why? |
| Catechin | 3 | 2018 | 244 | 1.25 | Why? |
| Humans | 435 | 2021 | 930598 | 1.25 | Why? |
| Cholecystectomy, Laparoscopic | 2 | 2018 | 120 | 1.24 | Why? |
| Carrier Proteins | 3 | 2018 | 513 | 1.23 | Why? |
| Mice, Inbred BALB C | 31 | 2020 | 5814 | 1.23 | Why? |
| Spinal Cord | 5 | 2018 | 281 | 1.18 | Why? |
| Emotions | 4 | 2018 | 2418 | 1.15 | Why? |
| Female | 242 | 2020 | 380317 | 1.15 | Why? |
| Gallbladder Neoplasms | 3 | 2019 | 30 | 1.14 | Why? |
| Tumor Suppressor Proteins | 2 | 2016 | 165 | 1.14 | Why? |
| Oxidative Stress | 11 | 2019 | 2050 | 1.14 | Why? |
| Male | 245 | 2020 | 367725 | 1.14 | Why? |
| Prostatic Neoplasms | 7 | 2018 | 1637 | 1.13 | Why? |
| Carcinoma, Squamous Cell | 7 | 2018 | 902 | 1.12 | Why? |
| Ovary | 5 | 2018 | 133 | 1.12 | Why? |
| Cell Survival | 27 | 2019 | 1581 | 1.12 | Why? |
| Matrix Metalloproteinase 9 | 6 | 2018 | 211 | 1.10 | Why? |
| Carcinogenesis | 8 | 2019 | 236 | 1.08 | Why? |
| Nanotubes, Carbon | 4 | 2018 | 71 | 1.08 | Why? |
| Lipopolysaccharides | 17 | 2019 | 848 | 1.07 | Why? |
| Astrocytes | 5 | 2018 | 298 | 1.06 | Why? |
| Lymphoma, Large B-Cell, Diffuse | 4 | 2018 | 176 | 1.06 | Why? |
| Liver Cirrhosis | 6 | 2018 | 1810 | 1.06 | Why? |
| Transcription Factors | 6 | 2019 | 784 | 1.05 | Why? |
| Neoplasm Proteins | 7 | 2019 | 501 | 1.04 | Why? |
| Mice, Inbred C57BL | 33 | 2020 | 5542 | 1.04 | Why? |
| Nanotechnology | 4 | 2018 | 821 | 1.04 | Why? |
| Small Cell Lung Carcinoma | 4 | 2019 | 133 | 1.04 | Why? |
| Immunotherapy, Adoptive | 2 | 2018 | 524 | 1.04 | Why? |
| Antigens, Neoplasm | 4 | 2018 | 230 | 1.03 | Why? |
| Islets of Langerhans Transplantation | 3 | 2018 | 41 | 1.03 | Why? |
| Proto-Oncogene Proteins c-akt | 10 | 2018 | 372 | 1.01 | Why? |
| Inflammasomes | 4 | 2019 | 710 | 1.01 | Why? |
| Nuclear Proteins | 6 | 2018 | 321 | 1.00 | Why? |
| Amyloid beta-Peptides | 4 | 2018 | 185 | 1.00 | Why? |
| STAT3 Transcription Factor | 4 | 2019 | 268 | 1.00 | Why? |
| Neoplasms, Experimental | 5 | 2018 | 67 | 1.00 | Why? |
| Cells, Cultured | 30 | 2019 | 5835 | 0.98 | Why? |
| Heterografts | 5 | 2018 | 203 | 0.98 | Why? |
| Smad3 Protein | 3 | 2018 | 40 | 0.96 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2019 | 1573 | 0.95 | Why? |
| Aortic Valve Insufficiency | 3 | 2018 | 136 | 0.95 | Why? |
| Genetic Predisposition to Disease | 9 | 2018 | 4027 | 0.94 | Why? |
| Transplantation, Heterologous | 4 | 2018 | 77 | 0.94 | Why? |
| Atherosclerosis | 4 | 2018 | 768 | 0.93 | Why? |
| Bone Resorption | 2 | 2019 | 61 | 0.93 | Why? |
| Diterpenes | 3 | 2018 | 157 | 0.93 | Why? |
| Glucosides | 4 | 2019 | 359 | 0.93 | Why? |
| Transforming Growth Factor beta | 4 | 2018 | 363 | 0.93 | Why? |
| Bone and Bones | 5 | 2018 | 235 | 0.92 | Why? |
| Adenocarcinoma | 7 | 2018 | 651 | 0.92 | Why? |
| Oryza | 4 | 2019 | 86 | 0.92 | Why? |
| Sp1 Transcription Factor | 2 | 2018 | 33 | 0.92 | Why? |
| RNA Interference | 11 | 2019 | 534 | 0.92 | Why? |
| Elasticity Imaging Techniques | 3 | 2018 | 194 | 0.92 | Why? |
| Cyclic AMP | 3 | 2018 | 76 | 0.92 | Why? |
| Xanthones | 2 | 2018 | 13 | 0.92 | Why? |
| Angiogenesis Inhibitors | 5 | 2018 | 395 | 0.91 | Why? |
| Magnetite Nanoparticles | 3 | 2017 | 109 | 0.91 | Why? |
| Silicosis | 2 | 2018 | 20 | 0.91 | Why? |
| Disease Models, Animal | 42 | 2019 | 10998 | 0.91 | Why? |
| Esophageal Neoplasms | 4 | 2019 | 357 | 0.91 | Why? |
| Receptor, Fibroblast Growth Factor, Type 1 | 4 | 2018 | 29 | 0.91 | Why? |
| Dopaminergic Neurons | 6 | 2018 | 59 | 0.91 | Why? |
| Proanthocyanidins | 2 | 2018 | 20 | 0.91 | Why? |
| Aldehyde Dehydrogenase | 2 | 2018 | 13 | 0.90 | Why? |
| Mammary Neoplasms, Animal | 2 | 2018 | 9 | 0.90 | Why? |
| Flavonoids | 4 | 2018 | 492 | 0.90 | Why? |
| Transcription Factor RelA | 5 | 2019 | 122 | 0.89 | Why? |
| Ultrasonography | 14 | 2019 | 4409 | 0.89 | Why? |
| Chromosome Aberrations | 2 | 2018 | 54 | 0.89 | Why? |
| Brain Stem | 3 | 2017 | 131 | 0.89 | Why? |
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2017 | 28 | 0.89 | Why? |
| Tissue Engineering | 4 | 2019 | 190 | 0.88 | Why? |
| Mesenchymal Stem Cell Transplantation | 5 | 2018 | 1322 | 0.88 | Why? |
| Stem Cells | 9 | 2019 | 595 | 0.88 | Why? |
| Paclitaxel | 2 | 2018 | 124 | 0.88 | Why? |
| Lysophospholipids | 2 | 2019 | 74 | 0.88 | Why? |
| Twist-Related Protein 1 | 2 | 2017 | 7 | 0.88 | Why? |
| Mitogen-Activated Protein Kinases | 2 | 2019 | 126 | 0.88 | Why? |
| Drug Resistance, Neoplasm | 9 | 2019 | 447 | 0.87 | Why? |
| Apoptosis Regulatory Proteins | 3 | 2018 | 202 | 0.87 | Why? |
| Hypoxia | 6 | 2018 | 3626 | 0.87 | Why? |
| Glycogen Synthase Kinase 3 beta | 2 | 2018 | 45 | 0.86 | Why? |
| Wound Healing | 6 | 2018 | 424 | 0.86 | Why? |
| Sphingosine | 2 | 2019 | 101 | 0.86 | Why? |
| Middle Aged | 150 | 2021 | 270681 | 0.85 | Why? |
| Neoplastic Stem Cells | 3 | 2018 | 120 | 0.85 | Why? |
| Hep G2 Cells | 15 | 2019 | 391 | 0.85 | Why? |
| Heme Oxygenase-1 | 2 | 2018 | 90 | 0.85 | Why? |
| Cholangiocarcinoma | 3 | 2017 | 186 | 0.85 | Why? |
| Polymorphism, Restriction Fragment Length | 3 | 2017 | 116 | 0.85 | Why? |
| Heroin | 1 | 2020 | 41 | 0.84 | Why? |
| Gene Knockdown Techniques | 5 | 2018 | 347 | 0.84 | Why? |
| Image Processing, Computer-Assisted | 3 | 2018 | 1383 | 0.84 | Why? |
| Lancelets | 1 | 2019 | 2 | 0.83 | Why? |
| Rats, Wistar | 11 | 2019 | 621 | 0.83 | Why? |
| Inflammation | 18 | 2019 | 13255 | 0.83 | Why? |
| Biflavonoids | 2 | 2018 | 80 | 0.83 | Why? |
| Signal-To-Noise Ratio | 2 | 2018 | 217 | 0.82 | Why? |
| Exons | 2 | 2017 | 158 | 0.82 | Why? |
| A549 Cells | 11 | 2019 | 2066 | 0.82 | Why? |
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2017 | 11 | 0.81 | Why? |
| Toll-Like Receptor 4 | 5 | 2018 | 390 | 0.81 | Why? |
| Diabetic Foot | 4 | 2018 | 317 | 0.80 | Why? |
| Craniotomy | 2 | 2018 | 123 | 0.80 | Why? |
| Compressive Strength | 1 | 2019 | 16 | 0.80 | Why? |
| Cyclooxygenase 2 | 3 | 2018 | 129 | 0.79 | Why? |
| Disease Progression | 15 | 2020 | 13580 | 0.79 | Why? |
| White spot syndrome virus 1 | 1 | 2018 | 1 | 0.79 | Why? |
| Malathion | 1 | 2018 | 3 | 0.79 | Why? |
| Sophora | 1 | 2018 | 1 | 0.79 | Why? |
| Diazinon | 1 | 2018 | 6 | 0.79 | Why? |
| Snail Family Transcription Factors | 1 | 2019 | 20 | 0.79 | Why? |
| Melilotus | 1 | 2018 | 1 | 0.79 | Why? |
| Mitogen-Activated Protein Kinase 1 | 3 | 2018 | 43 | 0.79 | Why? |
| Lim Kinases | 1 | 2018 | 5 | 0.79 | Why? |
| Dicistroviridae | 1 | 2018 | 8 | 0.79 | Why? |
| Mitogen-Activated Protein Kinase 3 | 3 | 2018 | 44 | 0.79 | Why? |
| Phenobarbital | 1 | 2019 | 22 | 0.79 | Why? |
| Retinoid X Receptors | 1 | 2018 | 7 | 0.79 | Why? |
| Hyperthermia, Induced | 2 | 2018 | 106 | 0.79 | Why? |
| Synoviocytes | 4 | 2019 | 13 | 0.79 | Why? |
| Cartilage | 1 | 2019 | 27 | 0.79 | Why? |
| Chemoembolization, Therapeutic | 2 | 2017 | 144 | 0.79 | Why? |
| Drug Delivery Systems | 8 | 2018 | 1365 | 0.78 | Why? |
| Reperfusion Injury | 5 | 2019 | 178 | 0.78 | Why? |
| Neoplasms | 18 | 2018 | 17251 | 0.78 | Why? |
| Janus Kinase 3 | 1 | 2019 | 46 | 0.78 | Why? |
| Isothiocyanates | 5 | 2019 | 29 | 0.78 | Why? |
| PC12 Cells | 1 | 2018 | 33 | 0.78 | Why? |
| Aminophylline | 1 | 2018 | 4 | 0.78 | Why? |
| Retinol-Binding Proteins, Plasma | 1 | 2018 | 4 | 0.78 | Why? |
| Prodrugs | 2 | 2018 | 264 | 0.78 | Why? |
| Distemper Virus, Canine | 1 | 2019 | 40 | 0.77 | Why? |
| Promoter Regions, Genetic | 6 | 2018 | 823 | 0.77 | Why? |
| Enhancer of Zeste Homolog 2 Protein | 2 | 2018 | 40 | 0.77 | Why? |
| Microfluidics | 2 | 2019 | 171 | 0.77 | Why? |
| src-Family Kinases | 2 | 2018 | 48 | 0.77 | Why? |
| Histones | 4 | 2018 | 371 | 0.77 | Why? |
| Carcinoma, Small Cell | 1 | 2018 | 16 | 0.76 | Why? |
| Xanthine Oxidase | 1 | 2018 | 20 | 0.76 | Why? |
| Chromosomes, Human, Pair 3 | 2 | 2017 | 195 | 0.76 | Why? |
| Drosophila | 1 | 2018 | 55 | 0.76 | Why? |
| Electrooculography | 1 | 2018 | 6 | 0.76 | Why? |
| Aurora Kinases | 1 | 2018 | 4 | 0.76 | Why? |
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 49 | 0.76 | Why? |
| Transcription Factor AP-1 | 1 | 2019 | 75 | 0.76 | Why? |
| Lipoproteins, LDL | 2 | 2019 | 115 | 0.76 | Why? |
| Gastrectomy | 2 | 2017 | 225 | 0.75 | Why? |
| Adult | 126 | 2020 | 244371 | 0.75 | Why? |
| Metalloendopeptidases | 1 | 2018 | 35 | 0.75 | Why? |
| Hydrogen Peroxide | 8 | 2019 | 680 | 0.75 | Why? |
| Cysteine | 2 | 2017 | 238 | 0.75 | Why? |
| Prognosis | 47 | 2020 | 32490 | 0.75 | Why? |
| Posterior Cruciate Ligament | 1 | 2018 | 5 | 0.75 | Why? |
| Genes, p53 | 2 | 2018 | 20 | 0.75 | Why? |
| Data Compression | 1 | 2018 | 16 | 0.75 | Why? |
| Bupivacaine | 1 | 2018 | 24 | 0.75 | Why? |
| Tissue Scaffolds | 3 | 2019 | 174 | 0.74 | Why? |
| Selenocysteine | 1 | 2018 | 6 | 0.74 | Why? |
| MDS1 and EVI1 Complex Locus Protein | 1 | 2017 | 2 | 0.74 | Why? |
| Adipose Tissue, Brown | 1 | 2018 | 20 | 0.74 | Why? |
| Mutation | 14 | 2019 | 12376 | 0.74 | Why? |
| RNA Polymerase II | 1 | 2018 | 29 | 0.74 | Why? |
| Spirostans | 4 | 2018 | 4 | 0.74 | Why? |
| TWEAK Receptor | 1 | 2018 | 46 | 0.74 | Why? |
| DNA | 5 | 2019 | 778 | 0.74 | Why? |
| Cyclin D1 | 2 | 2017 | 22 | 0.74 | Why? |
| Phosphocreatine | 1 | 2018 | 6 | 0.74 | Why? |
| Ultrasonography, Mammary | 1 | 2018 | 31 | 0.74 | Why? |
| Genes, Plant | 1 | 2018 | 42 | 0.74 | Why? |
| Esophagectomy | 1 | 2019 | 76 | 0.74 | Why? |
| Aralia | 1 | 2017 | 1 | 0.74 | Why? |
| Delayed Emergence from Anesthesia | 1 | 2018 | 5 | 0.74 | Why? |
| Indocyanine Green | 1 | 2018 | 66 | 0.74 | Why? |
| Ethiodized Oil | 1 | 2017 | 9 | 0.74 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 3 | 2019 | 581 | 0.74 | Why? |
| Evoked Potentials | 1 | 2018 | 44 | 0.73 | Why? |
| Mammary Neoplasms, Experimental | 1 | 2018 | 21 | 0.73 | Why? |
| Cytoplasmic Granules | 1 | 2018 | 53 | 0.73 | Why? |
| GTPase-Activating Proteins | 1 | 2018 | 36 | 0.73 | Why? |
| Post-Dural Puncture Headache | 1 | 2018 | 33 | 0.73 | Why? |
| Schizophrenic Psychology | 2 | 2019 | 198 | 0.73 | Why? |
| Lordosis | 1 | 2017 | 10 | 0.73 | Why? |
| Peroxidase | 3 | 2018 | 207 | 0.73 | Why? |
| Drosophila Proteins | 1 | 2018 | 67 | 0.73 | Why? |
| Apoptotic Protease-Activating Factor 1 | 1 | 2017 | 3 | 0.73 | Why? |
| Phthalazines | 1 | 2018 | 26 | 0.73 | Why? |
| Bone Marrow Cells | 2 | 2019 | 186 | 0.73 | Why? |
| Adipose Tissue, White | 1 | 2018 | 30 | 0.73 | Why? |
| Ulva | 1 | 2017 | 2 | 0.73 | Why? |
| Telomerase | 2 | 2017 | 45 | 0.73 | Why? |
| Interleukin-4 | 4 | 2018 | 367 | 0.73 | Why? |
| Myelodysplastic-Myeloproliferative Diseases | 1 | 2017 | 39 | 0.73 | Why? |
| Anesthesia Recovery Period | 1 | 2018 | 18 | 0.73 | Why? |
| Sterols | 1 | 2017 | 9 | 0.73 | Why? |
| Hypnosis | 1 | 2017 | 8 | 0.73 | Why? |
| Karyotype | 1 | 2017 | 16 | 0.73 | Why? |
| Adamantane | 1 | 2019 | 68 | 0.73 | Why? |
| Gene Expression Regulation, Leukemic | 2 | 2017 | 31 | 0.73 | Why? |
| Phosphorylation | 9 | 2019 | 1060 | 0.73 | Why? |
| Coronary Artery Disease | 6 | 2019 | 2570 | 0.72 | Why? |
| Keratin-17 | 1 | 2017 | 1 | 0.72 | Why? |
| Spine | 2 | 2018 | 292 | 0.72 | Why? |
| Phosphodiesterase Inhibitors | 1 | 2018 | 61 | 0.72 | Why? |
| Periaqueductal Gray | 1 | 2017 | 2 | 0.72 | Why? |
| Apolipoprotein A-I | 1 | 2019 | 148 | 0.72 | Why? |
| Migraine without Aura | 1 | 2017 | 14 | 0.72 | Why? |
| Panuveitis | 1 | 2018 | 46 | 0.72 | Why? |
| Thioredoxins | 1 | 2017 | 25 | 0.72 | Why? |
| Gene Regulatory Networks | 7 | 2019 | 820 | 0.72 | Why? |
| Lysine | 3 | 2018 | 153 | 0.72 | Why? |
| Hyperhomocysteinemia | 1 | 2017 | 24 | 0.72 | Why? |
| Ubiquitin-Conjugating Enzymes | 1 | 2017 | 27 | 0.72 | Why? |
| Hematoma, Subdural, Chronic | 1 | 2017 | 28 | 0.72 | Why? |
| Nerve Growth Factors | 1 | 2018 | 30 | 0.72 | Why? |
| Hepatic Artery | 1 | 2017 | 31 | 0.72 | Why? |
| Eye Movements | 1 | 2018 | 41 | 0.72 | Why? |
| Nomograms | 4 | 2019 | 790 | 0.72 | Why? |
| Benzoates | 1 | 2019 | 102 | 0.71 | Why? |
| Membrane Proteins | 7 | 2021 | 1733 | 0.71 | Why? |
| Thrombospondins | 1 | 2017 | 26 | 0.71 | Why? |
| T-Lymphocytes, Regulatory | 7 | 2019 | 698 | 0.71 | Why? |
| Nerve Regeneration | 1 | 2017 | 26 | 0.71 | Why? |
| Rotenone | 1 | 2017 | 7 | 0.71 | Why? |
| Hexokinase | 1 | 2017 | 10 | 0.71 | Why? |
| Hemagglutinins, Viral | 1 | 2019 | 176 | 0.71 | Why? |
| MCF-7 Cells | 7 | 2019 | 199 | 0.71 | Why? |
| Graft Survival | 3 | 2018 | 587 | 0.71 | Why? |
| Anesthesia, Epidural | 1 | 2018 | 92 | 0.71 | Why? |
| Skin Absorption | 1 | 2017 | 18 | 0.71 | Why? |
| Cholinesterase Inhibitors | 1 | 2018 | 99 | 0.71 | Why? |
| DNA Virus Infections | 1 | 2018 | 88 | 0.70 | Why? |
| Encephalitis, Japanese | 1 | 2018 | 58 | 0.70 | Why? |
| Contrast Media | 8 | 2018 | 1011 | 0.70 | Why? |
| Dysmenorrhea | 1 | 2017 | 17 | 0.70 | Why? |
| Dipeptides | 1 | 2019 | 106 | 0.70 | Why? |
| Reptiles | 1 | 2017 | 6 | 0.70 | Why? |
| POEMS Syndrome | 1 | 2017 | 13 | 0.70 | Why? |
| Drug Design | 7 | 2021 | 2627 | 0.70 | Why? |
| Creatine Kinase | 2 | 2017 | 386 | 0.70 | Why? |
| Ligaments | 2 | 2015 | 14 | 0.70 | Why? |
| Chlorophyta | 1 | 2017 | 36 | 0.70 | Why? |
| Evoked Potentials, Auditory | 1 | 2017 | 34 | 0.70 | Why? |
| Genetic Association Studies | 2 | 2018 | 559 | 0.70 | Why? |
| Ovariectomy | 1 | 2017 | 53 | 0.70 | Why? |
| Prostatitis | 1 | 2017 | 18 | 0.70 | Why? |
| Postanesthesia Nursing | 1 | 2017 | 3 | 0.70 | Why? |
| Primary Myelofibrosis | 1 | 2019 | 144 | 0.70 | Why? |
| Cytokines | 30 | 2020 | 15010 | 0.70 | Why? |
| Osteoblasts | 2 | 2017 | 87 | 0.70 | Why? |
| STAT Transcription Factors | 1 | 2018 | 173 | 0.70 | Why? |
| Ureteral Obstruction | 1 | 2018 | 61 | 0.70 | Why? |
| Telomere-Binding Proteins | 1 | 2017 | 4 | 0.70 | Why? |
| rab GTP-Binding Proteins | 1 | 2017 | 59 | 0.70 | Why? |
| Droughts | 1 | 2017 | 30 | 0.70 | Why? |
| Ankle Fractures | 1 | 2017 | 16 | 0.70 | Why? |
| Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 28 | 0.70 | Why? |
| Esophagogastric Junction | 1 | 2017 | 30 | 0.69 | Why? |
| Lymphocytes | 10 | 2020 | 3056 | 0.69 | Why? |
| Nanoshells | 1 | 2017 | 2 | 0.69 | Why? |
| Citalopram | 1 | 2017 | 44 | 0.69 | Why? |
| Auditory Perception | 1 | 2017 | 32 | 0.69 | Why? |
| beta Catenin | 2 | 2017 | 78 | 0.69 | Why? |
| Migraine with Aura | 1 | 2017 | 33 | 0.69 | Why? |
| Polyvinyl Alcohol | 1 | 2017 | 9 | 0.69 | Why? |
| Gallbladder Diseases | 1 | 2017 | 40 | 0.69 | Why? |
| Bacterial Adhesion | 1 | 2017 | 69 | 0.69 | Why? |
| Heroin Dependence | 1 | 2017 | 37 | 0.69 | Why? |
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2017 | 20 | 0.68 | Why? |
| Essential Hypertension | 1 | 2017 | 48 | 0.68 | Why? |
| Cytochrome P-450 CYP1A1 | 1 | 2017 | 39 | 0.68 | Why? |
| Transdermal Patch | 1 | 2017 | 52 | 0.68 | Why? |
| Nerve Net | 2 | 2018 | 118 | 0.68 | Why? |
| Oligonucleotide Array Sequence Analysis | 2 | 2018 | 343 | 0.68 | Why? |
| Preoperative Care | 2 | 2018 | 1515 | 0.68 | Why? |
| Drug Tolerance | 1 | 2017 | 100 | 0.68 | Why? |
| Retroviridae | 1 | 2017 | 49 | 0.67 | Why? |
| Fibrosis | 3 | 2019 | 800 | 0.67 | Why? |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2017 | 40 | 0.67 | Why? |
| Aortic Valve | 3 | 2018 | 664 | 0.67 | Why? |
| Benzopyrans | 1 | 2017 | 39 | 0.67 | Why? |
| Pituitary Neoplasms | 1 | 2019 | 130 | 0.67 | Why? |
| Caffeic Acids | 1 | 2017 | 54 | 0.67 | Why? |
| Morphine | 1 | 2017 | 71 | 0.67 | Why? |
| Soybeans | 1 | 2017 | 50 | 0.67 | Why? |
| Postoperative Complications | 8 | 2019 | 5861 | 0.67 | Why? |
| Quality Control | 2 | 2018 | 628 | 0.67 | Why? |
| Spinal Fusion | 1 | 2017 | 76 | 0.66 | Why? |
| Biomimetic Materials | 1 | 2017 | 70 | 0.66 | Why? |
| Glycolysis | 2 | 2017 | 208 | 0.66 | Why? |
| Receptors, CXCR3 | 1 | 2017 | 159 | 0.66 | Why? |
| Polycythemia Vera | 1 | 2018 | 113 | 0.66 | Why? |
| Aged | 112 | 2021 | 215776 | 0.66 | Why? |
| Endosonography | 1 | 2018 | 150 | 0.66 | Why? |
| Tumor Cells, Cultured | 9 | 2019 | 254 | 0.66 | Why? |
| Chemical and Drug Induced Liver Injury | 3 | 2018 | 451 | 0.66 | Why? |
| Facial Recognition | 1 | 2018 | 75 | 0.66 | Why? |
| Cervical Vertebrae | 2 | 2017 | 151 | 0.66 | Why? |
| Anti-Inflammatory Agents | 9 | 2018 | 6153 | 0.66 | Why? |
| Cholelithiasis | 1 | 2017 | 47 | 0.65 | Why? |
| Gap Junctions | 2 | 2018 | 18 | 0.65 | Why? |
| Rectal Neoplasms | 2 | 2018 | 278 | 0.65 | Why? |
| Phototherapy | 1 | 2018 | 138 | 0.65 | Why? |
| Kruppel-Like Transcription Factors | 1 | 2017 | 91 | 0.65 | Why? |
| Pulmonary Emphysema | 1 | 2018 | 122 | 0.65 | Why? |
| Extracellular Matrix | 4 | 2019 | 189 | 0.65 | Why? |
| Janus Kinase 1 | 1 | 2019 | 254 | 0.64 | Why? |
| B7-H1 Antigen | 2 | 2019 | 541 | 0.64 | Why? |
| Vascular Endothelial Growth Factor A | 6 | 2018 | 604 | 0.64 | Why? |
| Posture | 1 | 2018 | 199 | 0.64 | Why? |
| Autophagy-Related Proteins | 1 | 2017 | 157 | 0.64 | Why? |
| Equipment Safety | 1 | 2018 | 167 | 0.64 | Why? |
| Nuclear Receptor Co-Repressor 1 | 1 | 2015 | 4 | 0.64 | Why? |
| Microvessels | 2 | 2018 | 490 | 0.64 | Why? |
| Interleukin-17 | 3 | 2017 | 602 | 0.64 | Why? |
| Urinary Bladder Neoplasms | 3 | 2018 | 614 | 0.64 | Why? |
| Psychological Tests | 1 | 2017 | 152 | 0.63 | Why? |
| Diabetic Angiopathies | 1 | 2018 | 146 | 0.63 | Why? |
| RNA Virus Infections | 1 | 2018 | 231 | 0.63 | Why? |
| Intraoperative Care | 1 | 2018 | 238 | 0.63 | Why? |
| Cell Line | 29 | 2019 | 12040 | 0.63 | Why? |
| Consciousness | 1 | 2018 | 140 | 0.63 | Why? |
| Patient Handoff | 1 | 2017 | 68 | 0.63 | Why? |
| Retinal Detachment | 1 | 2018 | 146 | 0.62 | Why? |
| Insulin | 4 | 2018 | 1316 | 0.62 | Why? |
| Movement | 1 | 2018 | 232 | 0.62 | Why? |
| Hypertension, Portal | 1 | 2017 | 73 | 0.62 | Why? |
| Drug Screening Assays, Antitumor | 11 | 2019 | 138 | 0.62 | Why? |
| Spinal Cord Injuries | 2 | 2017 | 270 | 0.62 | Why? |
| Fluorouracil | 5 | 2019 | 169 | 0.62 | Why? |
| Case-Control Studies | 23 | 2020 | 17671 | 0.62 | Why? |
| Brain | 11 | 2020 | 5133 | 0.62 | Why? |
| Anesthesia, Spinal | 1 | 2018 | 178 | 0.62 | Why? |
| Plant Proteins | 1 | 2018 | 194 | 0.62 | Why? |
| Saponins | 1 | 2017 | 171 | 0.61 | Why? |
| Janus Kinases | 2 | 2018 | 414 | 0.61 | Why? |
| Aorta, Thoracic | 1 | 2018 | 271 | 0.61 | Why? |
| Pancytopenia | 1 | 2017 | 113 | 0.61 | Why? |
| Ischemic Attack, Transient | 2 | 2017 | 439 | 0.61 | Why? |
| Herpesviridae Infections | 1 | 2018 | 172 | 0.61 | Why? |
| Nanostructures | 3 | 2019 | 700 | 0.61 | Why? |
| Disease-Free Survival | 11 | 2019 | 1654 | 0.60 | Why? |
| Microglia | 6 | 2018 | 357 | 0.60 | Why? |
| Structure-Activity Relationship | 16 | 2019 | 2219 | 0.60 | Why? |
| Neuropilin-1 | 1 | 2018 | 284 | 0.60 | Why? |
| Arthroplasty, Replacement, Knee | 2 | 2018 | 363 | 0.60 | Why? |
| Acute Lung Injury | 3 | 2019 | 904 | 0.60 | Why? |
| Papain | 1 | 2018 | 257 | 0.60 | Why? |
| Triterpenes | 1 | 2018 | 199 | 0.60 | Why? |
| RNA, Messenger | 22 | 2019 | 5131 | 0.60 | Why? |
| Dose-Response Relationship, Drug | 21 | 2019 | 3776 | 0.60 | Why? |
| Laryngeal Neoplasms | 1 | 2018 | 202 | 0.60 | Why? |
| Polymerase Chain Reaction | 9 | 2019 | 6740 | 0.59 | Why? |
| Primary Ovarian Insufficiency | 4 | 2018 | 19 | 0.59 | Why? |
| Fracture Fixation | 1 | 2017 | 128 | 0.59 | Why? |
| Myasthenia Gravis | 2 | 2018 | 385 | 0.59 | Why? |
| Tobacco Use Disorder | 1 | 2018 | 163 | 0.59 | Why? |
| Genotyping Techniques | 2 | 2017 | 360 | 0.59 | Why? |
| Multimodal Imaging | 3 | 2018 | 534 | 0.59 | Why? |
| Mitochondria | 4 | 2019 | 857 | 0.59 | Why? |
| Enterotoxins | 2 | 2018 | 115 | 0.58 | Why? |
| Nasopharyngeal Neoplasms | 2 | 2018 | 64 | 0.58 | Why? |
| Osteogenesis | 5 | 2019 | 95 | 0.58 | Why? |
| Programmed Cell Death 1 Receptor | 2 | 2017 | 724 | 0.58 | Why? |
| Up-Regulation | 15 | 2019 | 2249 | 0.58 | Why? |
| Anesthetists | 1 | 2017 | 186 | 0.58 | Why? |
| Viral Fusion Proteins | 1 | 2019 | 399 | 0.57 | Why? |
| Hepatitis B virus | 4 | 2018 | 882 | 0.57 | Why? |
| Antagomirs | 3 | 2018 | 16 | 0.57 | Why? |
| Endosomes | 2 | 2019 | 490 | 0.57 | Why? |
| Aortic Aneurysm, Abdominal | 1 | 2017 | 155 | 0.57 | Why? |
| Transcatheter Aortic Valve Replacement | 3 | 2018 | 839 | 0.57 | Why? |
| Oligopeptides | 5 | 2018 | 576 | 0.57 | Why? |
| Anesthesia, Obstetrical | 1 | 2018 | 230 | 0.57 | Why? |
| Transcription, Genetic | 2 | 2018 | 1326 | 0.56 | Why? |
| Bile Duct Neoplasms | 1 | 2017 | 172 | 0.56 | Why? |
| Image Interpretation, Computer-Assisted | 2 | 2018 | 665 | 0.56 | Why? |
| Diabetic Nephropathies | 1 | 2018 | 315 | 0.56 | Why? |
| Neoplasm Metastasis | 8 | 2018 | 682 | 0.56 | Why? |
| Skin | 6 | 2019 | 2096 | 0.56 | Why? |
| Ovarian Neoplasms | 2 | 2017 | 465 | 0.56 | Why? |
| Radiotherapy Planning, Computer-Assisted | 2 | 2018 | 172 | 0.56 | Why? |
| Carcinoma, Renal Cell | 2 | 2018 | 545 | 0.56 | Why? |
| Brain-Derived Neurotrophic Factor | 4 | 2019 | 133 | 0.56 | Why? |
| Infarction, Middle Cerebral Artery | 3 | 2019 | 203 | 0.56 | Why? |
| Recovery of Function | 6 | 2018 | 2461 | 0.56 | Why? |
| G2 Phase Cell Cycle Checkpoints | 3 | 2018 | 25 | 0.55 | Why? |
| Glioblastoma | 1 | 2017 | 187 | 0.55 | Why? |
| Polymers | 4 | 2018 | 507 | 0.55 | Why? |
| Quinazolines | 5 | 2018 | 126 | 0.55 | Why? |
| Microscopy | 1 | 2018 | 414 | 0.55 | Why? |
| Laparoscopy | 5 | 2018 | 1532 | 0.55 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2018 | 127 | 0.55 | Why? |
| Cigarette Smoking | 1 | 2018 | 337 | 0.55 | Why? |
| Psychological Theory | 1 | 2017 | 226 | 0.55 | Why? |
| Genetic Loci | 2 | 2017 | 439 | 0.55 | Why? |
| Epstein-Barr Virus Infections | 2 | 2018 | 366 | 0.55 | Why? |
| Acupuncture Therapy | 1 | 2018 | 234 | 0.54 | Why? |
| Swine | 9 | 2018 | 3352 | 0.54 | Why? |
| Gene Expression Profiling | 7 | 2018 | 3788 | 0.54 | Why? |
| Neurogenesis | 3 | 2018 | 64 | 0.54 | Why? |
| Pedigree | 5 | 2018 | 502 | 0.54 | Why? |
| Operative Time | 5 | 2019 | 450 | 0.53 | Why? |
| Cell Cycle Proteins | 5 | 2018 | 297 | 0.53 | Why? |
| Alzheimer Disease | 3 | 2018 | 1020 | 0.53 | Why? |
| Biomedical Technology | 1 | 2018 | 257 | 0.53 | Why? |
| Peptide Fragments | 4 | 2018 | 2075 | 0.53 | Why? |
| Leukemia, Myeloid, Acute | 3 | 2018 | 676 | 0.53 | Why? |
| Papillomaviridae | 1 | 2018 | 404 | 0.52 | Why? |
| Plant Extracts | 5 | 2018 | 1514 | 0.52 | Why? |
| Lab-On-A-Chip Devices | 1 | 2017 | 411 | 0.52 | Why? |
| Follow-Up Studies | 22 | 2019 | 17020 | 0.52 | Why? |
| Aortic Diseases | 1 | 2018 | 362 | 0.52 | Why? |
| Catalytic Domain | 2 | 2018 | 1757 | 0.52 | Why? |
| Gene Silencing | 5 | 2018 | 213 | 0.52 | Why? |
| Proto-Oncogene Proteins c-met | 3 | 2017 | 40 | 0.52 | Why? |
| Deoxycytidine | 3 | 2019 | 116 | 0.52 | Why? |
| Endemic Diseases | 1 | 2018 | 480 | 0.52 | Why? |
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 436 | 0.52 | Why? |
| Translocation, Genetic | 3 | 2017 | 40 | 0.52 | Why? |
| Personality | 1 | 2017 | 277 | 0.52 | Why? |
| Random Allocation | 7 | 2018 | 773 | 0.51 | Why? |
| Mood Disorders | 1 | 2017 | 431 | 0.51 | Why? |
| Sirtuin 1 | 3 | 2019 | 100 | 0.51 | Why? |
| Doxorubicin | 5 | 2018 | 313 | 0.51 | Why? |
| Enzyme Inhibitors | 3 | 2018 | 1881 | 0.51 | Why? |
| Models, Psychological | 1 | 2017 | 383 | 0.51 | Why? |
| Polyethylene Glycols | 1 | 2018 | 574 | 0.51 | Why? |
| Gene Transfer Techniques | 3 | 2018 | 134 | 0.51 | Why? |
| High-Throughput Screening Assays | 3 | 2019 | 1783 | 0.51 | Why? |
| Cunninghamella | 1 | 2012 | 9 | 0.50 | Why? |
| Chemokine CXCL10 | 1 | 2017 | 565 | 0.50 | Why? |
| Prostatectomy | 1 | 2018 | 485 | 0.50 | Why? |
| Equipment and Supplies | 1 | 2018 | 440 | 0.50 | Why? |
| Aortic Valve Stenosis | 2 | 2018 | 741 | 0.50 | Why? |
| Tomography, X-Ray Computed | 13 | 2021 | 25144 | 0.50 | Why? |
| Stress, Physiological | 1 | 2017 | 378 | 0.50 | Why? |
| Mutation, Missense | 3 | 2018 | 863 | 0.49 | Why? |
| Kidney Neoplasms | 2 | 2018 | 832 | 0.49 | Why? |
| Proto-Oncogene Proteins | 5 | 2018 | 340 | 0.49 | Why? |
| Vaccines, Attenuated | 1 | 2018 | 952 | 0.49 | Why? |
| China | 36 | 2020 | 50654 | 0.49 | Why? |
| Exosomes | 2 | 2018 | 567 | 0.49 | Why? |
| Gallic Acid | 3 | 2019 | 49 | 0.49 | Why? |
| Schizophrenia | 3 | 2019 | 1018 | 0.49 | Why? |
| Liver | 8 | 2018 | 4007 | 0.48 | Why? |
| Cisplatin | 3 | 2019 | 209 | 0.48 | Why? |
| Transfection | 9 | 2018 | 864 | 0.48 | Why? |
| RAW 264.7 Cells | 5 | 2019 | 316 | 0.48 | Why? |
| HeLa Cells | 7 | 2019 | 1303 | 0.48 | Why? |
| Genomics | 4 | 2017 | 3118 | 0.47 | Why? |
| Blotting, Western | 5 | 2018 | 863 | 0.47 | Why? |
| Endothelial Progenitor Cells | 3 | 2017 | 103 | 0.47 | Why? |
| Microchemistry | 2 | 2013 | 3 | 0.46 | Why? |
| Protein-Tyrosine Kinases | 3 | 2017 | 158 | 0.46 | Why? |
| Peripheral Arterial Disease | 1 | 2018 | 471 | 0.46 | Why? |
| Renal Insufficiency, Chronic | 4 | 2019 | 2654 | 0.46 | Why? |
| Apamin | 1 | 2011 | 1 | 0.46 | Why? |
| Molecular Targeted Therapy | 5 | 2019 | 1579 | 0.46 | Why? |
| Young Adult | 50 | 2020 | 93724 | 0.46 | Why? |
| Databases, Genetic | 2 | 2018 | 1127 | 0.46 | Why? |
| Cell Adhesion | 5 | 2019 | 230 | 0.46 | Why? |
| Antineoplastic Agents, Phytogenic | 3 | 2018 | 183 | 0.46 | Why? |
| Neural Inhibition | 1 | 2011 | 19 | 0.45 | Why? |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2017 | 877 | 0.45 | Why? |
| Affect | 1 | 2017 | 549 | 0.45 | Why? |
| Cell Cycle | 9 | 2019 | 329 | 0.45 | Why? |
| Heart | 2 | 2019 | 1791 | 0.45 | Why? |
| Arachidonic Acids | 1 | 2011 | 36 | 0.45 | Why? |
| Killer Cells, Natural | 2 | 2018 | 2093 | 0.45 | Why? |
| Smad Proteins | 4 | 2019 | 19 | 0.44 | Why? |
| Deception | 1 | 2015 | 225 | 0.44 | Why? |
| Bone Marrow | 6 | 2018 | 492 | 0.44 | Why? |
| Hemodynamics | 2 | 2019 | 1562 | 0.44 | Why? |
| HLA-C Antigens | 2 | 2017 | 195 | 0.44 | Why? |
| Neuralgia | 3 | 2018 | 99 | 0.44 | Why? |
| Neuroglia | 1 | 2011 | 130 | 0.43 | Why? |
| Chromatography, High Pressure Liquid | 5 | 2019 | 669 | 0.43 | Why? |
| HLA-A Antigens | 2 | 2017 | 196 | 0.43 | Why? |
| Arthritis, Rheumatoid | 3 | 2019 | 2043 | 0.43 | Why? |
| RANK Ligand | 3 | 2019 | 47 | 0.43 | Why? |
| Carcinoembryonic Antigen | 2 | 2018 | 140 | 0.43 | Why? |
| Diet, High-Fat | 4 | 2018 | 161 | 0.43 | Why? |
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2017 | 291 | 0.42 | Why? |
| Withholding Treatment | 1 | 2017 | 798 | 0.42 | Why? |
| Rabbits | 7 | 2019 | 1171 | 0.42 | Why? |
| Micro-Electrical-Mechanical Systems | 1 | 2010 | 13 | 0.42 | Why? |
| Tumor Necrosis Factor-alpha | 13 | 2019 | 2483 | 0.42 | Why? |
| Response Elements | 1 | 2010 | 54 | 0.42 | Why? |
| Hepatocytes | 3 | 2019 | 549 | 0.41 | Why? |
| Drugs, Chinese Herbal | 4 | 2019 | 2760 | 0.41 | Why? |
| Benzamides | 3 | 2018 | 421 | 0.41 | Why? |
| Animals, Newborn | 4 | 2018 | 350 | 0.41 | Why? |
| Chromosomes, Plant | 3 | 2018 | 19 | 0.41 | Why? |
| Superantigens | 1 | 2010 | 53 | 0.41 | Why? |
| Peptide Hydrolases | 1 | 2018 | 1269 | 0.41 | Why? |
| Ventricular Dysfunction, Left | 1 | 2019 | 993 | 0.41 | Why? |
| Gene Expression | 8 | 2019 | 3332 | 0.41 | Why? |
| Medication Adherence | 2 | 2019 | 1270 | 0.41 | Why? |
| NFATC Transcription Factors | 3 | 2018 | 22 | 0.41 | Why? |
| Polyethyleneimine | 3 | 2020 | 37 | 0.41 | Why? |
| Computed Tomography Angiography | 2 | 2018 | 2153 | 0.41 | Why? |
| Fluorescent Dyes | 3 | 2018 | 536 | 0.41 | Why? |
| Neural Stem Cells | 4 | 2018 | 135 | 0.41 | Why? |
| Karyotyping | 3 | 2017 | 52 | 0.40 | Why? |
| Phosphatidylinositol 3-Kinase | 3 | 2017 | 28 | 0.40 | Why? |
| Retrospective Studies | 38 | 2021 | 105322 | 0.40 | Why? |
| Neoplasm Transplantation | 3 | 2017 | 55 | 0.40 | Why? |
| Reproducibility of Results | 17 | 2019 | 11304 | 0.40 | Why? |
| Solutions | 1 | 2010 | 121 | 0.40 | Why? |
| Printing | 1 | 2009 | 4 | 0.40 | Why? |
| Oncogenes | 2 | 2019 | 23 | 0.40 | Why? |
| Glioma | 3 | 2019 | 189 | 0.40 | Why? |
| Kaplan-Meier Estimate | 13 | 2018 | 4260 | 0.40 | Why? |
| Enzyme Activation | 4 | 2018 | 425 | 0.40 | Why? |
| Aorta | 5 | 2019 | 355 | 0.40 | Why? |
| Aged, 80 and over | 40 | 2019 | 88759 | 0.40 | Why? |
| Proto-Oncogene Proteins c-mdm2 | 3 | 2017 | 35 | 0.39 | Why? |
| Biomarkers | 23 | 2020 | 23361 | 0.39 | Why? |
| Histidine | 2 | 2019 | 72 | 0.39 | Why? |
| Neoplasm Staging | 9 | 2018 | 1999 | 0.39 | Why? |
| Thromboplastin | 1 | 2011 | 275 | 0.39 | Why? |
| Radiotherapy, Intensity-Modulated | 1 | 2010 | 148 | 0.39 | Why? |
| Cell Cycle Checkpoints | 6 | 2019 | 126 | 0.39 | Why? |
| I-kappa B Proteins | 2 | 2019 | 21 | 0.39 | Why? |
| Metabolic Networks and Pathways | 4 | 2018 | 285 | 0.38 | Why? |
| Self Report | 3 | 2018 | 3802 | 0.38 | Why? |
| Trans-Activators | 3 | 2019 | 170 | 0.38 | Why? |
| Wnt Signaling Pathway | 3 | 2018 | 87 | 0.38 | Why? |
| Chondrocytes | 4 | 2019 | 35 | 0.38 | Why? |
| Tumor Necrosis Factor alpha-Induced Protein 3 | 2 | 2018 | 29 | 0.38 | Why? |
| Gene Dosage | 3 | 2017 | 101 | 0.38 | Why? |
| Cysteine Endopeptidases | 1 | 2018 | 1557 | 0.38 | Why? |
| Proto-Oncogene Proteins c-kit | 2 | 2019 | 59 | 0.38 | Why? |
| Keratinocytes | 3 | 2018 | 119 | 0.38 | Why? |
| MAP Kinase Kinase 4 | 2 | 2019 | 36 | 0.38 | Why? |
| Bone Morphogenetic Protein 2 | 2 | 2019 | 24 | 0.38 | Why? |
| Cell Communication | 1 | 2011 | 396 | 0.38 | Why? |
| Treatment Outcome | 35 | 2020 | 51732 | 0.38 | Why? |
| Proto-Oncogene Proteins c-myc | 2 | 2019 | 43 | 0.38 | Why? |
| Quercetin | 3 | 2019 | 297 | 0.37 | Why? |
| Chronic Pain | 2 | 2017 | 736 | 0.37 | Why? |
| Parabens | 2 | 2018 | 6 | 0.37 | Why? |
| Adolescent | 41 | 2020 | 86841 | 0.37 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.37 | Why? |
| Pseudomonas chlororaphis | 2 | 2018 | 2 | 0.37 | Why? |
| Femur Head Necrosis | 2 | 2019 | 25 | 0.37 | Why? |
| Tandem Mass Spectrometry | 4 | 2018 | 1031 | 0.37 | Why? |
| Oligodendrocyte Precursor Cells | 2 | 2018 | 7 | 0.37 | Why? |
| Motor Activity | 4 | 2018 | 217 | 0.37 | Why? |
| M Phase Cell Cycle Checkpoints | 2 | 2018 | 9 | 0.37 | Why? |
| Colonic Neoplasms | 3 | 2018 | 295 | 0.36 | Why? |
| Naphthoquinones | 2 | 2019 | 87 | 0.36 | Why? |
| Internal Ribosome Entry Sites | 2 | 2018 | 9 | 0.36 | Why? |
| Cytomegalovirus | 3 | 2018 | 600 | 0.36 | Why? |
| Neovascularization, Physiologic | 3 | 2018 | 160 | 0.36 | Why? |
| Acrylamides | 2 | 2018 | 40 | 0.36 | Why? |
| Genistein | 2 | 2018 | 25 | 0.36 | Why? |
| 3' Untranslated Regions | 3 | 2018 | 318 | 0.36 | Why? |
| Pyrrolidines | 1 | 2012 | 558 | 0.36 | Why? |
| Mice, Knockout | 12 | 2019 | 1815 | 0.36 | Why? |
| Beclin-1 | 2 | 2018 | 38 | 0.35 | Why? |
| Lignans | 2 | 2018 | 41 | 0.35 | Why? |
| Myeloproliferative Disorders | 3 | 2017 | 507 | 0.35 | Why? |
| Genes, myc | 2 | 2017 | 15 | 0.35 | Why? |
| Ammonia | 2 | 2018 | 61 | 0.35 | Why? |
| Hydrogen Sulfide | 2 | 2019 | 86 | 0.35 | Why? |
| Alleles | 4 | 2017 | 1557 | 0.35 | Why? |
| Diagnosis, Differential | 11 | 2018 | 7220 | 0.35 | Why? |
| Stem Cell Transplantation | 3 | 2018 | 531 | 0.35 | Why? |
| Genes, Tumor Suppressor | 2 | 2018 | 43 | 0.35 | Why? |
| Hepatocyte Growth Factor | 2 | 2018 | 71 | 0.35 | Why? |
| Coronary Angiography | 2 | 2018 | 2275 | 0.35 | Why? |
| Glycyrrhetinic Acid | 2 | 2018 | 30 | 0.35 | Why? |
| Molecular Structure | 10 | 2018 | 1539 | 0.35 | Why? |
| DNA Repair | 2 | 2018 | 114 | 0.35 | Why? |
| DNA Replication | 2 | 2018 | 121 | 0.35 | Why? |
| Cellular Reprogramming | 2 | 2019 | 117 | 0.35 | Why? |
| Kidney | 6 | 2019 | 3648 | 0.35 | Why? |
| Heart Valve Prosthesis | 3 | 2018 | 533 | 0.35 | Why? |
| Blood Loss, Surgical | 3 | 2018 | 211 | 0.35 | Why? |
| Fibroblasts | 4 | 2019 | 839 | 0.35 | Why? |
| Melanoma | 1 | 2019 | 1229 | 0.35 | Why? |
| Oncogene Proteins, Fusion | 2 | 2018 | 52 | 0.34 | Why? |
| Fluoxetine | 2 | 2018 | 77 | 0.34 | Why? |
| Axons | 2 | 2018 | 73 | 0.34 | Why? |
| Equipment Design | 6 | 2018 | 3095 | 0.34 | Why? |
| Intercellular Signaling Peptides and Proteins | 3 | 2018 | 245 | 0.34 | Why? |
| Image-Guided Biopsy | 3 | 2018 | 185 | 0.34 | Why? |
| Hydrogels | 3 | 2019 | 173 | 0.34 | Why? |
| Proteomics | 2 | 2019 | 2481 | 0.34 | Why? |
| Attitude | 1 | 2017 | 1481 | 0.34 | Why? |
| Interferon Type I | 1 | 2021 | 2789 | 0.34 | Why? |
| Dinoprostone | 2 | 2018 | 101 | 0.34 | Why? |
| Neutrophils | 7 | 2020 | 5476 | 0.34 | Why? |
| DNA Transposable Elements | 2 | 2018 | 91 | 0.34 | Why? |
| Proteome | 1 | 2018 | 1812 | 0.34 | Why? |
| Calcium Channel Blockers | 1 | 2011 | 367 | 0.34 | Why? |
| Biocompatible Materials | 3 | 2019 | 214 | 0.34 | Why? |
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2017 | 76 | 0.34 | Why? |
| Electrocardiography | 3 | 2018 | 3957 | 0.34 | Why? |
| Analgesics, Opioid | 1 | 2017 | 1070 | 0.34 | Why? |
| Collagen | 3 | 2019 | 222 | 0.34 | Why? |
| Preimplantation Diagnosis | 2 | 2017 | 16 | 0.33 | Why? |
| Telomere Homeostasis | 2 | 2017 | 52 | 0.33 | Why? |
| Length of Stay | 6 | 2018 | 11042 | 0.33 | Why? |
| Range of Motion, Articular | 2 | 2018 | 168 | 0.33 | Why? |
| Genome, Human | 4 | 2019 | 400 | 0.33 | Why? |
| Inflammation Mediators | 8 | 2019 | 2654 | 0.33 | Why? |
| Administration, Cutaneous | 2 | 2018 | 229 | 0.33 | Why? |
| RNA Stability | 2 | 2019 | 285 | 0.33 | Why? |
| Brain Neoplasms | 3 | 2019 | 669 | 0.33 | Why? |
| Chalcones | 2 | 2017 | 83 | 0.33 | Why? |
| Lymphoma, Follicular | 2 | 2018 | 109 | 0.33 | Why? |
| Oleanolic Acid | 2 | 2018 | 82 | 0.33 | Why? |
| Behavior, Animal | 5 | 2019 | 136 | 0.33 | Why? |
| Bone Density | 3 | 2019 | 335 | 0.33 | Why? |
| Phenylurea Compounds | 2 | 2017 | 101 | 0.32 | Why? |
| Insulin-Like Growth Factor I | 2 | 2018 | 119 | 0.32 | Why? |
| Pulmonary Disease, Chronic Obstructive | 4 | 2018 | 3832 | 0.32 | Why? |
| Chitosan | 4 | 2020 | 196 | 0.32 | Why? |
| Endoscopy | 1 | 2017 | 1564 | 0.32 | Why? |
| Pyrimidines | 4 | 2020 | 1557 | 0.32 | Why? |
| Receptor, ErbB-2 | 2 | 2019 | 267 | 0.32 | Why? |
| Vitamin D | 3 | 2018 | 2904 | 0.32 | Why? |
| Cerebral Small Vessel Diseases | 2 | 2017 | 89 | 0.32 | Why? |
| Stilbenes | 2 | 2018 | 113 | 0.32 | Why? |
| Phenotype | 10 | 2019 | 4037 | 0.31 | Why? |
| Survival Rate | 11 | 2019 | 9206 | 0.31 | Why? |
| Lipids | 4 | 2018 | 1079 | 0.31 | Why? |
| Epigenesis, Genetic | 5 | 2019 | 711 | 0.31 | Why? |
| Regenerative Medicine | 2 | 2018 | 161 | 0.31 | Why? |
| Natural Killer T-Cells | 2 | 2018 | 191 | 0.31 | Why? |
| Retinal Ganglion Cells | 2 | 2018 | 80 | 0.31 | Why? |
| Prostate | 3 | 2017 | 283 | 0.31 | Why? |
| Fracture Fixation, Internal | 2 | 2019 | 188 | 0.31 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2017 | 1671 | 0.31 | Why? |
| DNA Mutational Analysis | 3 | 2017 | 581 | 0.31 | Why? |
| Laser Therapy | 2 | 2019 | 158 | 0.31 | Why? |
| Image Enhancement | 2 | 2018 | 177 | 0.31 | Why? |
| T-Lymphocytes | 5 | 2020 | 6670 | 0.31 | Why? |
| Th17 Cells | 4 | 2019 | 657 | 0.31 | Why? |
| Lipid Metabolism | 4 | 2018 | 572 | 0.31 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 2 | 2021 | 800 | 0.31 | Why? |
| Biphenyl Compounds | 2 | 2017 | 249 | 0.31 | Why? |
| Chromatography, Liquid | 3 | 2018 | 640 | 0.30 | Why? |
| Membrane Potentials | 2 | 2018 | 56 | 0.30 | Why? |
| Protein Isoforms | 5 | 2018 | 347 | 0.30 | Why? |
| Immunohistochemistry | 10 | 2018 | 2275 | 0.30 | Why? |
| Logistic Models | 7 | 2019 | 9089 | 0.30 | Why? |
| Telomere | 2 | 2018 | 146 | 0.30 | Why? |
| White Matter | 3 | 2018 | 369 | 0.30 | Why? |
| Osteoarthritis, Knee | 2 | 2018 | 158 | 0.30 | Why? |
| Adipose Tissue | 4 | 2018 | 612 | 0.30 | Why? |
| Pharmaceutical Preparations | 1 | 2020 | 1897 | 0.30 | Why? |
| B-Lymphocytes | 2 | 2018 | 4418 | 0.30 | Why? |
| Colitis | 2 | 2019 | 266 | 0.30 | Why? |
| Cerebellum | 2 | 2018 | 119 | 0.30 | Why? |
| Echocardiography | 2 | 2019 | 3661 | 0.30 | Why? |
| Immunotherapy | 3 | 2017 | 2421 | 0.30 | Why? |
| Protein Transport | 5 | 2018 | 487 | 0.30 | Why? |
| Neural Conduction | 2 | 2017 | 261 | 0.29 | Why? |
| Trophoblasts | 2 | 2017 | 237 | 0.29 | Why? |
| Parkinson Disease | 4 | 2018 | 1414 | 0.29 | Why? |
| Risk Factors | 24 | 2020 | 71621 | 0.29 | Why? |
| Binding Sites | 7 | 2018 | 6201 | 0.29 | Why? |
| Protein Binding | 7 | 2018 | 11430 | 0.29 | Why? |
| Osteoarthritis | 2 | 2018 | 205 | 0.29 | Why? |
| Carotid Stenosis | 2 | 2019 | 207 | 0.29 | Why? |
| Interleukin-1beta | 7 | 2019 | 992 | 0.29 | Why? |
| Skin Neoplasms | 1 | 2019 | 1679 | 0.29 | Why? |
| Adenosine | 3 | 2018 | 509 | 0.29 | Why? |
| Hypothermia, Induced | 2 | 2017 | 176 | 0.29 | Why? |
| Prospective Studies | 20 | 2019 | 43301 | 0.28 | Why? |
| Catheter Ablation | 3 | 2018 | 438 | 0.28 | Why? |
| CD8-Positive T-Lymphocytes | 3 | 2018 | 5837 | 0.28 | Why? |
| Psoriasis | 1 | 2019 | 1739 | 0.28 | Why? |
| Cell Lineage | 4 | 2019 | 241 | 0.28 | Why? |
| Chemokine CCL2 | 2 | 2017 | 389 | 0.28 | Why? |
| Fibroblast Growth Factors | 2 | 2018 | 119 | 0.28 | Why? |
| Glucose | 3 | 2017 | 573 | 0.28 | Why? |
| Myocardial Infarction | 3 | 2017 | 3361 | 0.28 | Why? |
| Seizures | 3 | 2018 | 1163 | 0.28 | Why? |
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 502 | 0.28 | Why? |
| Urinary Bladder | 2 | 2018 | 170 | 0.28 | Why? |
| Chronic Disease | 2 | 2018 | 5139 | 0.28 | Why? |
| Core Binding Factor Alpha 1 Subunit | 3 | 2019 | 12 | 0.28 | Why? |
| Acute Coronary Syndrome | 1 | 2018 | 2107 | 0.28 | Why? |
| Tetrazoles | 2 | 2017 | 262 | 0.28 | Why? |
| Imaging, Three-Dimensional | 3 | 2018 | 680 | 0.27 | Why? |
| Neoplastic Cells, Circulating | 2 | 2018 | 68 | 0.27 | Why? |
| Multivariate Analysis | 8 | 2018 | 5440 | 0.27 | Why? |
| Light | 2 | 2018 | 306 | 0.27 | Why? |
| Herpesvirus 4, Human | 2 | 2018 | 387 | 0.27 | Why? |
| Benzimidazoles | 2 | 2017 | 275 | 0.27 | Why? |
| Recombination, Genetic | 1 | 2011 | 1265 | 0.27 | Why? |
| Biosensing Techniques | 2 | 2018 | 2116 | 0.27 | Why? |
| Quality Improvement | 1 | 2017 | 2435 | 0.27 | Why? |
| Viral Load | 5 | 2018 | 15850 | 0.27 | Why? |
| Drug Discovery | 5 | 2018 | 3092 | 0.27 | Why? |
| Chemistry Techniques, Synthetic | 3 | 2018 | 60 | 0.27 | Why? |
| HEK293 Cells | 7 | 2019 | 8394 | 0.27 | Why? |
| Gene Frequency | 3 | 2017 | 1210 | 0.26 | Why? |
| Interleukin-8 | 2 | 2020 | 964 | 0.26 | Why? |
| Base Sequence | 8 | 2019 | 3581 | 0.26 | Why? |
| Combined Modality Therapy | 6 | 2019 | 3395 | 0.26 | Why? |
| Epithelial Cells | 6 | 2019 | 3508 | 0.26 | Why? |
| Models, Molecular | 10 | 2020 | 7616 | 0.26 | Why? |
| Hepatectomy | 2 | 2017 | 276 | 0.26 | Why? |
| In Situ Nick-End Labeling | 3 | 2017 | 39 | 0.26 | Why? |
| Cholesterol, LDL | 2 | 2017 | 499 | 0.26 | Why? |
| Colorectal Neoplasms | 4 | 2018 | 1884 | 0.26 | Why? |
| Percutaneous Coronary Intervention | 2 | 2018 | 3646 | 0.26 | Why? |
| Gene Rearrangement | 3 | 2018 | 84 | 0.26 | Why? |
| Mice, Inbred ICR | 6 | 2019 | 242 | 0.26 | Why? |
| Molecular Conformation | 3 | 2019 | 374 | 0.26 | Why? |
| Neoplasm Recurrence, Local | 4 | 2018 | 1063 | 0.25 | Why? |
| Intracellular Signaling Peptides and Proteins | 4 | 2018 | 334 | 0.25 | Why? |
| Gene Amplification | 3 | 2017 | 85 | 0.25 | Why? |
| Receptors, Notch | 3 | 2019 | 59 | 0.25 | Why? |
| Clinical Competence | 1 | 2018 | 3263 | 0.25 | Why? |
| Lenses, Intraocular | 2 | 2019 | 15 | 0.25 | Why? |
| Bacteria | 3 | 2019 | 1897 | 0.25 | Why? |
| Erythrocytes | 3 | 2018 | 617 | 0.25 | Why? |
| Leukemia | 2 | 2018 | 598 | 0.25 | Why? |
| Databases, Factual | 7 | 2019 | 6248 | 0.24 | Why? |
| Chi-Square Distribution | 4 | 2018 | 961 | 0.24 | Why? |
| Tomography, Optical Coherence | 3 | 2019 | 1008 | 0.24 | Why? |
| Neoplasm Grading | 3 | 2018 | 400 | 0.24 | Why? |
| Cytoprotection | 2 | 2019 | 44 | 0.24 | Why? |
| Anti-Bacterial Agents | 3 | 2019 | 10083 | 0.24 | Why? |
| Spectrometry, Mass, Electrospray Ionization | 4 | 2018 | 159 | 0.24 | Why? |
| Smad2 Protein | 2 | 2018 | 20 | 0.24 | Why? |
| TOR Serine-Threonine Kinases | 4 | 2017 | 385 | 0.24 | Why? |
| DNA Copy Number Variations | 2 | 2019 | 84 | 0.24 | Why? |
| Infertility, Male | 2 | 2017 | 322 | 0.24 | Why? |
| Genetic Vectors | 5 | 2019 | 1600 | 0.24 | Why? |
| Recombinant Fusion Proteins | 2 | 2018 | 919 | 0.24 | Why? |
| Antigens, CD1d | 2 | 2018 | 12 | 0.24 | Why? |
| Metabolomics | 2 | 2018 | 921 | 0.24 | Why? |
| Cartilage, Articular | 2 | 2019 | 50 | 0.24 | Why? |
| HMGB1 Protein | 3 | 2020 | 223 | 0.24 | Why? |
| Interferon-gamma | 5 | 2018 | 2711 | 0.23 | Why? |
| Kidney Failure, Chronic | 1 | 2018 | 3222 | 0.23 | Why? |
| Metabolic Engineering | 2 | 2018 | 41 | 0.23 | Why? |
| Indazoles | 2 | 2019 | 77 | 0.23 | Why? |
| Extracellular Signal-Regulated MAP Kinases | 2 | 2019 | 92 | 0.23 | Why? |
| Connexin 43 | 2 | 2018 | 37 | 0.23 | Why? |
| Insulin Resistance | 2 | 2018 | 669 | 0.23 | Why? |
| Tuberculosis | 1 | 2018 | 2895 | 0.23 | Why? |
| Adaptor Protein Complex beta Subunits | 1 | 2021 | 13 | 0.23 | Why? |
| Adaptor Protein Complex 3 | 1 | 2021 | 14 | 0.23 | Why? |
| Aspartate Aminotransferases | 3 | 2017 | 1394 | 0.23 | Why? |
| Gliosis | 2 | 2018 | 16 | 0.23 | Why? |
| HCT116 Cells | 2 | 2018 | 83 | 0.23 | Why? |
| Galactosamine | 2 | 2018 | 18 | 0.23 | Why? |
| U937 Cells | 2 | 2018 | 77 | 0.23 | Why? |
| Culture Media, Conditioned | 2 | 2018 | 66 | 0.23 | Why? |
| Tyrphostins | 2 | 2017 | 7 | 0.23 | Why? |
| Collagen Type II | 2 | 2019 | 12 | 0.23 | Why? |
| Pancreatic Neoplasms | 3 | 2018 | 609 | 0.23 | Why? |
| T-Lymphocyte Subsets | 3 | 2018 | 1387 | 0.23 | Why? |
| Margins of Excision | 2 | 2019 | 122 | 0.23 | Why? |
| Oligodendroglia | 2 | 2018 | 57 | 0.23 | Why? |
| Philadelphia Chromosome | 2 | 2018 | 38 | 0.23 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.23 | Why? |
| Matrix Metalloproteinase 2 | 2 | 2018 | 85 | 0.23 | Why? |
| Organic Cation Transport Proteins | 2 | 2017 | 37 | 0.23 | Why? |
| Receptors, Cholinergic | 2 | 2018 | 70 | 0.23 | Why? |
| Camptothecin | 2 | 2018 | 39 | 0.23 | Why? |
| Diabetes Mellitus, Type 2 | 3 | 2017 | 6166 | 0.23 | Why? |
| Animals, Genetically Modified | 2 | 2018 | 230 | 0.22 | Why? |
| Trastuzumab | 2 | 2019 | 108 | 0.22 | Why? |
| Calcium Phosphates | 2 | 2018 | 35 | 0.22 | Why? |
| Osteocalcin | 2 | 2017 | 31 | 0.22 | Why? |
| Renin-Angiotensin System | 1 | 2017 | 3661 | 0.22 | Why? |
| Dogs | 4 | 2019 | 2529 | 0.22 | Why? |
| Mice, Inbred Strains | 2 | 2018 | 136 | 0.22 | Why? |
| Mice, SCID | 3 | 2017 | 225 | 0.22 | Why? |
| Monocytes | 3 | 2019 | 2978 | 0.22 | Why? |
| Hepatitis B, Chronic | 2 | 2018 | 616 | 0.22 | Why? |
| Phantoms, Imaging | 2 | 2018 | 146 | 0.22 | Why? |
| Facial Expression | 2 | 2018 | 74 | 0.22 | Why? |
| Ganglia, Spinal | 2 | 2018 | 44 | 0.22 | Why? |
| Adenine | 3 | 2018 | 463 | 0.22 | Why? |
| Chemokine CCL7 | 1 | 2020 | 39 | 0.22 | Why? |
| Temporal Lobe | 2 | 2018 | 83 | 0.22 | Why? |
| Hypoglycemic Agents | 3 | 2019 | 2165 | 0.22 | Why? |
| Cell Death | 3 | 2018 | 536 | 0.22 | Why? |
| Genotype | 4 | 2018 | 4697 | 0.22 | Why? |
| Color | 2 | 2018 | 92 | 0.22 | Why? |
| Hepatitis B | 3 | 2018 | 888 | 0.22 | Why? |
| Antineoplastic Agents, Immunological | 2 | 2018 | 830 | 0.22 | Why? |
| Extracellular Matrix Proteins | 2 | 2019 | 95 | 0.22 | Why? |
| Flow Cytometry | 10 | 2019 | 2393 | 0.22 | Why? |
| Receptor, IGF Type 1 | 2 | 2017 | 24 | 0.22 | Why? |
| Unfolded Protein Response | 2 | 2018 | 134 | 0.21 | Why? |
| Aneuploidy | 2 | 2017 | 27 | 0.21 | Why? |
| Transcriptional Activation | 2 | 2018 | 196 | 0.21 | Why? |
| Piperidines | 2 | 2017 | 795 | 0.21 | Why? |
| Nitric Oxide | 2 | 2019 | 769 | 0.21 | Why? |
| Biopsy | 4 | 2018 | 2811 | 0.21 | Why? |
| Hirudin Therapy | 1 | 2019 | 2 | 0.21 | Why? |
| Stroke | 5 | 2018 | 8839 | 0.21 | Why? |
| Recombinant Proteins | 4 | 2018 | 3786 | 0.21 | Why? |
| Genome-Wide Association Study | 2 | 2018 | 1648 | 0.21 | Why? |
| Blood Flow Velocity | 2 | 2019 | 193 | 0.21 | Why? |
| Quaternary Ammonium Compounds | 2 | 2020 | 136 | 0.21 | Why? |
| Anoctamin-1 | 1 | 2019 | 4 | 0.21 | Why? |
| Amnion | 2 | 2018 | 55 | 0.21 | Why? |
| Cerebral Cortex | 3 | 2018 | 276 | 0.21 | Why? |
| Odds Ratio | 5 | 2018 | 5861 | 0.21 | Why? |
| DNA Fragmentation | 2 | 2017 | 67 | 0.21 | Why? |
| Biomechanical Phenomena | 2 | 2018 | 291 | 0.21 | Why? |
| Lymphoma, T-Cell, Peripheral | 1 | 2019 | 12 | 0.21 | Why? |
| Proportional Hazards Models | 9 | 2018 | 6543 | 0.21 | Why? |
| Receptors, CXCR4 | 2 | 2019 | 83 | 0.21 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.21 | Why? |
| Temperature | 4 | 2018 | 2305 | 0.21 | Why? |
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2017 | 66 | 0.21 | Why? |
| Respiratory Hypersensitivity | 2 | 2019 | 103 | 0.21 | Why? |
| Influenza A Virus, H2N2 Subtype | 1 | 2019 | 6 | 0.21 | Why? |
| Lymphocytes, Tumor-Infiltrating | 2 | 2017 | 130 | 0.21 | Why? |
| Ependymoma | 1 | 2019 | 5 | 0.21 | Why? |
| Tongue Neoplasms | 2 | 2017 | 54 | 0.21 | Why? |
| Tenuivirus | 1 | 2019 | 2 | 0.21 | Why? |
| Hemiptera | 1 | 2019 | 4 | 0.21 | Why? |
| Dental Papilla | 1 | 2019 | 1 | 0.21 | Why? |
| Odontogenesis | 1 | 2019 | 2 | 0.21 | Why? |
| Alcoholism | 2 | 2018 | 691 | 0.20 | Why? |
| Magnetic Resonance Spectroscopy | 4 | 2018 | 881 | 0.20 | Why? |
| Probiotics | 2 | 2019 | 694 | 0.20 | Why? |
| GPI-Linked Proteins | 2 | 2018 | 317 | 0.20 | Why? |
| Biopsy, Needle | 2 | 2018 | 303 | 0.20 | Why? |
| Posterior Horn Cells | 1 | 2019 | 3 | 0.20 | Why? |
| Liver X Receptors | 1 | 2019 | 13 | 0.20 | Why? |
| Molecular Imaging | 2 | 2018 | 110 | 0.20 | Why? |
| Chlorogenic Acid | 1 | 2019 | 25 | 0.20 | Why? |
| Faecalibacterium prausnitzii | 1 | 2019 | 1 | 0.20 | Why? |
| Cues | 1 | 2020 | 86 | 0.20 | Why? |
| Cullin Proteins | 1 | 2019 | 31 | 0.20 | Why? |
| Proteins | 2 | 2018 | 921 | 0.20 | Why? |
| Smoking | 3 | 2018 | 3358 | 0.20 | Why? |
| Long-Term Potentiation | 1 | 2019 | 19 | 0.20 | Why? |
| Silicon Dioxide | 3 | 2017 | 131 | 0.20 | Why? |
| Tantalum | 1 | 2019 | 8 | 0.20 | Why? |
| Calgranulin A | 1 | 2020 | 74 | 0.20 | Why? |
| Octamer Transcription Factor-3 | 1 | 2019 | 17 | 0.20 | Why? |
| Bone Lengthening | 1 | 2019 | 2 | 0.20 | Why? |
| Anterior Eye Segment | 1 | 2019 | 23 | 0.20 | Why? |
| Foot Deformities, Acquired | 1 | 2019 | 2 | 0.20 | Why? |
| Hyperuricemia | 2 | 2017 | 160 | 0.20 | Why? |
| Iridectomy | 1 | 2019 | 14 | 0.20 | Why? |
| Dermatitis, Atopic | 2 | 2018 | 714 | 0.20 | Why? |
| Coptis | 1 | 2018 | 1 | 0.20 | Why? |
| Rehmannia | 1 | 2018 | 1 | 0.20 | Why? |
| Mice, Inbred NOD | 2 | 2017 | 134 | 0.20 | Why? |
| Pesticides | 2 | 2018 | 100 | 0.20 | Why? |
| Phenylephrine | 1 | 2019 | 20 | 0.20 | Why? |
| Interleukin-2 | 2 | 2018 | 443 | 0.20 | Why? |
| Viral Proteins | 1 | 2018 | 7370 | 0.20 | Why? |
| Surgical Wound | 1 | 2019 | 20 | 0.20 | Why? |
| Bevacizumab | 2 | 2018 | 149 | 0.20 | Why? |
| Hirudins | 1 | 2019 | 75 | 0.20 | Why? |
| GA-Binding Protein Transcription Factor | 1 | 2018 | 1 | 0.20 | Why? |
| Calgranulin B | 1 | 2020 | 144 | 0.20 | Why? |
| Arisaema | 1 | 2018 | 1 | 0.20 | Why? |
| Chromatids | 1 | 2018 | 4 | 0.20 | Why? |
| Arteriosclerosis Obliterans | 1 | 2018 | 5 | 0.20 | Why? |
| Calcaneus | 1 | 2019 | 13 | 0.20 | Why? |
| Peripheral Nerve Injuries | 2 | 2018 | 114 | 0.20 | Why? |
| Sclera | 1 | 2019 | 31 | 0.20 | Why? |
| Insect Proteins | 1 | 2019 | 39 | 0.20 | Why? |
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2018 | 5 | 0.20 | Why? |
| Tryptophan | 2 | 2019 | 218 | 0.20 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2018 | 2984 | 0.20 | Why? |
| Scutellaria baicalensis | 1 | 2019 | 30 | 0.20 | Why? |
| Proto-Oncogene Proteins c-ets | 1 | 2018 | 5 | 0.20 | Why? |
| Chemokine CXCL12 | 1 | 2019 | 74 | 0.20 | Why? |
| Carbonic Anhydrase IX | 1 | 2018 | 11 | 0.20 | Why? |
| Daphne | 1 | 2018 | 2 | 0.20 | Why? |
| Argonaute Proteins | 1 | 2019 | 55 | 0.19 | Why? |
| Allografts | 3 | 2017 | 761 | 0.19 | Why? |
| Thanatophoric Dysplasia | 1 | 2018 | 3 | 0.19 | Why? |
| Smad5 Protein | 1 | 2018 | 4 | 0.19 | Why? |
| Endothelial Cells | 4 | 2019 | 2048 | 0.19 | Why? |
| Shikimic Acid | 1 | 2018 | 1 | 0.19 | Why? |
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2018 | 9 | 0.19 | Why? |
| Alkaline Phosphatase | 2 | 2017 | 257 | 0.19 | Why? |
| Osteotomy | 1 | 2019 | 30 | 0.19 | Why? |
| CD59 Antigens | 1 | 2018 | 9 | 0.19 | Why? |
| Nuclear Transfer Techniques | 1 | 2018 | 6 | 0.19 | Why? |
| SOXB1 Transcription Factors | 1 | 2018 | 20 | 0.19 | Why? |
| Positron Emission Tomography Computed Tomography | 3 | 2018 | 1458 | 0.19 | Why? |
| rho-Associated Kinases | 1 | 2018 | 32 | 0.19 | Why? |
| Auranofin | 1 | 2019 | 37 | 0.19 | Why? |
| Pseudolymphoma | 1 | 2018 | 11 | 0.19 | Why? |
| Chromosomal Proteins, Non-Histone | 1 | 2018 | 33 | 0.19 | Why? |
| rhoA GTP-Binding Protein | 1 | 2018 | 24 | 0.19 | Why? |
| Lizards | 1 | 2018 | 13 | 0.19 | Why? |
| Knee Joint | 2 | 2018 | 194 | 0.19 | Why? |
| Materials Testing | 3 | 2017 | 380 | 0.19 | Why? |
| Carcinoma, Ductal, Breast | 2 | 2018 | 149 | 0.19 | Why? |
| Industrial Microbiology | 1 | 2018 | 20 | 0.19 | Why? |
| Centella | 1 | 2018 | 4 | 0.19 | Why? |
| Neoplasms, Neuroepithelial | 1 | 2018 | 4 | 0.19 | Why? |
| CD55 Antigens | 1 | 2018 | 14 | 0.19 | Why? |
| Foot Injuries | 1 | 2019 | 35 | 0.19 | Why? |
| Acetophenones | 1 | 2018 | 7 | 0.19 | Why? |
| Cyclin B1 | 1 | 2018 | 7 | 0.19 | Why? |
| Tubulin | 1 | 2018 | 67 | 0.19 | Why? |
| Maternal Serum Screening Tests | 1 | 2018 | 17 | 0.19 | Why? |
| NFI Transcription Factors | 1 | 2018 | 1 | 0.19 | Why? |
| Spatial Learning | 1 | 2018 | 7 | 0.19 | Why? |
| Tooth Exfoliation | 1 | 2018 | 1 | 0.19 | Why? |
| CDC2 Protein Kinase | 1 | 2018 | 6 | 0.19 | Why? |
| Cevanes | 1 | 2018 | 2 | 0.19 | Why? |
| Receptor Protein-Tyrosine Kinases | 2 | 2017 | 243 | 0.19 | Why? |
| Lens Implantation, Intraocular | 1 | 2019 | 62 | 0.19 | Why? |
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2018 | 5 | 0.19 | Why? |
| Solute Carrier Family 12, Member 2 | 1 | 2018 | 2 | 0.19 | Why? |
| Bumetanide | 1 | 2018 | 2 | 0.19 | Why? |
| Organs at Risk | 1 | 2018 | 48 | 0.19 | Why? |
| Benzene Derivatives | 1 | 2018 | 6 | 0.19 | Why? |
| Leukemia, Mast-Cell | 1 | 2018 | 2 | 0.19 | Why? |
| Immunomodulation | 2 | 2018 | 1472 | 0.19 | Why? |
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 10 | 0.19 | Why? |
| Odontoblasts | 1 | 2018 | 2 | 0.19 | Why? |
| Cofilin 1 | 1 | 2018 | 4 | 0.19 | Why? |
| Growth Cones | 1 | 2018 | 2 | 0.19 | Why? |
| Polycomb Repressive Complex 1 | 1 | 2018 | 6 | 0.19 | Why? |
| Cell Nucleus | 2 | 2018 | 399 | 0.19 | Why? |
| Caspase 9 | 1 | 2018 | 38 | 0.19 | Why? |
| Repetitive Sequences, Nucleic Acid | 1 | 2018 | 28 | 0.19 | Why? |
| Astrocytoma | 1 | 2018 | 29 | 0.19 | Why? |
| Immediate-Early Proteins | 1 | 2018 | 44 | 0.19 | Why? |
| Ubiquitin-Specific Proteases | 1 | 2018 | 31 | 0.19 | Why? |
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2018 | 1 | 0.19 | Why? |
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2018 | 65 | 0.19 | Why? |
| NIH 3T3 Cells | 1 | 2018 | 147 | 0.19 | Why? |
| Follistatin-Related Proteins | 1 | 2018 | 18 | 0.19 | Why? |
| Autocrine Communication | 1 | 2018 | 14 | 0.19 | Why? |
| Retinal Telangiectasis | 1 | 2018 | 4 | 0.19 | Why? |
| Radiotherapy, Conformal | 1 | 2018 | 49 | 0.19 | Why? |
| Wolfram Syndrome | 1 | 2018 | 2 | 0.19 | Why? |
| Hair Follicle | 1 | 2019 | 44 | 0.19 | Why? |
| S Phase Cell Cycle Checkpoints | 1 | 2018 | 21 | 0.19 | Why? |
| Echinococcus multilocularis | 1 | 2018 | 5 | 0.19 | Why? |
| Blood Pressure | 4 | 2017 | 2198 | 0.19 | Why? |
| Thyroid Carcinoma, Anaplastic | 1 | 2018 | 16 | 0.19 | Why? |
| Transcription Factor RelB | 1 | 2018 | 9 | 0.19 | Why? |
| Heterogeneous Nuclear Ribonucleoprotein A1 | 1 | 2018 | 15 | 0.19 | Why? |
| Chromosomes, Human, Pair 12 | 1 | 2018 | 84 | 0.19 | Why? |
| Brain Ischemia | 3 | 2019 | 2813 | 0.19 | Why? |
| Radio Waves | 1 | 2018 | 27 | 0.19 | Why? |
| Adrenal Gland Neoplasms | 1 | 2019 | 70 | 0.19 | Why? |
| Serine-Arginine Splicing Factors | 1 | 2018 | 14 | 0.19 | Why? |
| Rubus | 1 | 2018 | 7 | 0.19 | Why? |
| Cricetulus | 5 | 2019 | 936 | 0.19 | Why? |
| Asthma | 4 | 2019 | 4383 | 0.19 | Why? |
| Randomized Controlled Trials as Topic | 5 | 2018 | 10649 | 0.19 | Why? |
| Autophagy-Related Protein 5 | 1 | 2018 | 28 | 0.19 | Why? |
| Consciousness Monitors | 1 | 2018 | 11 | 0.19 | Why? |
| Recurrence | 3 | 2018 | 3675 | 0.19 | Why? |
| Galactosyltransferases | 1 | 2018 | 69 | 0.19 | Why? |
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2018 | 28 | 0.19 | Why? |
| Glaucoma, Angle-Closure | 1 | 2019 | 46 | 0.19 | Why? |
| Peroxiredoxins | 1 | 2018 | 13 | 0.19 | Why? |
| Epoxy Compounds | 1 | 2018 | 21 | 0.19 | Why? |
| Bone Morphogenetic Protein 7 | 1 | 2017 | 5 | 0.19 | Why? |
| Uricosuric Agents | 1 | 2017 | 4 | 0.19 | Why? |
| Tooth, Deciduous | 1 | 2018 | 22 | 0.19 | Why? |
| Dioscorea | 1 | 2017 | 3 | 0.19 | Why? |
| AC133 Antigen | 1 | 2018 | 19 | 0.19 | Why? |
| Receptors, Purinergic P1 | 1 | 2018 | 17 | 0.19 | Why? |
| Electromyography | 2 | 2017 | 278 | 0.19 | Why? |
| Epidermal Growth Factor | 1 | 2018 | 44 | 0.19 | Why? |
| Breast | 2 | 2018 | 290 | 0.19 | Why? |
| NIMA-Related Kinases | 1 | 2018 | 9 | 0.19 | Why? |
| Enzyme Induction | 1 | 2018 | 89 | 0.19 | Why? |
| Children's Health Insurance Program | 1 | 2018 | 12 | 0.18 | Why? |
| Sulfotransferases | 1 | 2018 | 25 | 0.18 | Why? |
| Femur Head | 1 | 2018 | 18 | 0.18 | Why? |
| Suppressor of Cytokine Signaling Proteins | 1 | 2018 | 13 | 0.18 | Why? |
| Anticarcinogenic Agents | 1 | 2018 | 25 | 0.18 | Why? |
| Micelles | 1 | 2018 | 96 | 0.18 | Why? |
| Tripterygium | 1 | 2018 | 15 | 0.18 | Why? |
| Acetabulum | 1 | 2018 | 18 | 0.18 | Why? |
| Knee | 1 | 2018 | 35 | 0.18 | Why? |
| Femur Neck | 1 | 2018 | 29 | 0.18 | Why? |
| Diosgenin | 1 | 2017 | 8 | 0.18 | Why? |
| Mitochondrial Diseases | 1 | 2019 | 62 | 0.18 | Why? |
| Streptomyces | 1 | 2018 | 51 | 0.18 | Why? |
| beta-Alanine | 1 | 2018 | 20 | 0.18 | Why? |
| Sapogenins | 1 | 2017 | 3 | 0.18 | Why? |
| Forkhead Box Protein O1 | 1 | 2018 | 31 | 0.18 | Why? |
| Diabetic Neuropathies | 1 | 2019 | 64 | 0.18 | Why? |
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2018 | 25 | 0.18 | Why? |
| Porifera | 1 | 2018 | 29 | 0.18 | Why? |
| Spondylosis | 1 | 2017 | 4 | 0.18 | Why? |
| Wnt-5a Protein | 1 | 2018 | 14 | 0.18 | Why? |
| Sperm Tail | 1 | 2017 | 3 | 0.18 | Why? |
| Tibia | 1 | 2018 | 72 | 0.18 | Why? |
| Teratoma | 1 | 2018 | 25 | 0.18 | Why? |
| Diastole | 1 | 2019 | 168 | 0.18 | Why? |
| Kinetics | 5 | 2017 | 3238 | 0.18 | Why? |
| Goats | 1 | 2019 | 217 | 0.18 | Why? |
| High-Intensity Focused Ultrasound Ablation | 1 | 2018 | 19 | 0.18 | Why? |
| Plant Components, Aerial | 1 | 2017 | 12 | 0.18 | Why? |
| ortho-Aminobenzoates | 1 | 2018 | 46 | 0.18 | Why? |
| Chromosome Disorders | 1 | 2018 | 24 | 0.18 | Why? |
| Dopamine Antagonists | 1 | 2017 | 13 | 0.18 | Why? |
| Phenylacetates | 1 | 2017 | 4 | 0.18 | Why? |
| bcl-Associated Death Protein | 1 | 2017 | 8 | 0.18 | Why? |
| Prunus armeniaca | 1 | 2017 | 1 | 0.18 | Why? |
| Nerve Transfer | 1 | 2017 | 3 | 0.18 | Why? |
| Mohs Surgery | 1 | 2019 | 70 | 0.18 | Why? |
| Masseter Muscle | 1 | 2017 | 9 | 0.18 | Why? |
| Deoxyribonuclease HpaII | 1 | 2017 | 1 | 0.18 | Why? |
| Nerve Tissue Proteins | 2 | 2018 | 319 | 0.18 | Why? |
| Aldehyde Reductase | 1 | 2017 | 4 | 0.18 | Why? |
| Ultrasonic Waves | 1 | 2018 | 32 | 0.18 | Why? |
| Sulpiride | 1 | 2017 | 11 | 0.18 | Why? |
| Spleen | 4 | 2020 | 877 | 0.18 | Why? |
| Sulfoxides | 4 | 2019 | 43 | 0.18 | Why? |
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2018 | 26 | 0.18 | Why? |
| Intervertebral Disc | 1 | 2018 | 16 | 0.18 | Why? |
| Polyploidy | 1 | 2017 | 16 | 0.18 | Why? |
| 4-Butyrolactone | 1 | 2018 | 18 | 0.18 | Why? |
| Activins | 1 | 2018 | 26 | 0.18 | Why? |
| Electron Transport Complex I | 1 | 2017 | 12 | 0.18 | Why? |
| Antibodies, Neoplasm | 1 | 2017 | 15 | 0.18 | Why? |
| Diskectomy | 1 | 2017 | 12 | 0.18 | Why? |
| Mandibular Condyle | 1 | 2017 | 5 | 0.18 | Why? |
| GATA4 Transcription Factor | 1 | 2017 | 6 | 0.18 | Why? |
| Fas Ligand Protein | 1 | 2018 | 69 | 0.18 | Why? |
| Video-Assisted Surgery | 1 | 2018 | 43 | 0.18 | Why? |
| Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 43 | 0.18 | Why? |
| Cholecystolithiasis | 1 | 2017 | 5 | 0.18 | Why? |
| Proto-Oncogene Proteins c-ret | 1 | 2017 | 15 | 0.18 | Why? |
| RNAi Therapeutics | 1 | 2018 | 35 | 0.18 | Why? |
| Silicon | 1 | 2018 | 31 | 0.18 | Why? |
| Lewy Body Disease | 1 | 2018 | 36 | 0.18 | Why? |
| Paracrine Communication | 1 | 2018 | 73 | 0.18 | Why? |
| Kynurenine | 1 | 2019 | 140 | 0.18 | Why? |
| Amplified Fragment Length Polymorphism Analysis | 1 | 2017 | 11 | 0.18 | Why? |
| Radiography | 3 | 2019 | 1576 | 0.18 | Why? |
| Adenosine Triphosphate | 2 | 2018 | 294 | 0.18 | Why? |
| Tartrate-Resistant Acid Phosphatase | 1 | 2017 | 7 | 0.18 | Why? |
| Nephrolithiasis | 1 | 2017 | 11 | 0.18 | Why? |
| Bone Cements | 1 | 2018 | 21 | 0.18 | Why? |
| Dimethoate | 1 | 2017 | 1 | 0.18 | Why? |
| Melphalan | 1 | 2017 | 46 | 0.18 | Why? |
| Smiling | 1 | 2017 | 5 | 0.18 | Why? |
| Receptors, Laminin | 1 | 2017 | 6 | 0.18 | Why? |
| Dendritic Cells, Follicular | 1 | 2017 | 3 | 0.18 | Why? |
| Angina, Stable | 1 | 2018 | 45 | 0.18 | Why? |
| Galectin 1 | 1 | 2017 | 15 | 0.18 | Why? |
| Carcinoma, Adenosquamous | 1 | 2017 | 17 | 0.18 | Why? |
| Mastitis | 2 | 2015 | 27 | 0.18 | Why? |
| Tarsal Bones | 1 | 2017 | 3 | 0.18 | Why? |
| Myeloid Differentiation Factor 88 | 1 | 2018 | 109 | 0.18 | Why? |
| Mandibular Reconstruction | 1 | 2017 | 14 | 0.18 | Why? |
| Receptors, Purinergic P2X7 | 1 | 2018 | 35 | 0.18 | Why? |
| Microscopy, Electron | 2 | 2018 | 830 | 0.18 | Why? |
| CA-19-9 Antigen | 1 | 2017 | 22 | 0.18 | Why? |
| Thumb | 1 | 2018 | 42 | 0.18 | Why? |
| Morpholines | 2 | 2017 | 351 | 0.18 | Why? |
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2018 | 49 | 0.18 | Why? |
| HSP90 Heat-Shock Proteins | 1 | 2018 | 98 | 0.18 | Why? |
| Cystamine | 1 | 2017 | 5 | 0.18 | Why? |
| 3-Hydroxybutyric Acid | 1 | 2017 | 16 | 0.18 | Why? |
| Electrons | 1 | 2018 | 53 | 0.18 | Why? |
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 26 | 0.18 | Why? |
| Ulnar Nerve | 1 | 2017 | 12 | 0.18 | Why? |
| Enterovirus B, Human | 1 | 2019 | 124 | 0.18 | Why? |
| Aortography | 1 | 2018 | 60 | 0.18 | Why? |
| fms-Like Tyrosine Kinase 3 | 1 | 2017 | 43 | 0.18 | Why? |
| Histocytochemistry | 1 | 2017 | 88 | 0.18 | Why? |
| Mitogen-Activated Protein Kinase 7 | 1 | 2017 | 6 | 0.18 | Why? |
| Cyclothymic Disorder | 1 | 2017 | 29 | 0.18 | Why? |
| Pyrazoles | 2 | 2020 | 1791 | 0.18 | Why? |
| Feedback, Physiological | 1 | 2017 | 56 | 0.18 | Why? |
| Histone Demethylases | 1 | 2018 | 31 | 0.18 | Why? |
| Acoustic Stimulation | 1 | 2017 | 20 | 0.18 | Why? |
| fas Receptor | 1 | 2018 | 85 | 0.18 | Why? |
| Chromosomes, Human, Pair 22 | 1 | 2017 | 10 | 0.18 | Why? |
| Hepatic Stellate Cells | 1 | 2017 | 35 | 0.18 | Why? |
| Forkhead Box Protein O3 | 1 | 2017 | 30 | 0.18 | Why? |
| Fibroblast Growth Factor 2 | 1 | 2018 | 77 | 0.18 | Why? |
| Patient Education as Topic | 2 | 2018 | 1476 | 0.18 | Why? |
| Cell Engineering | 1 | 2017 | 23 | 0.18 | Why? |
| CDC2-CDC28 Kinases | 1 | 2017 | 2 | 0.18 | Why? |
| T-Cell Antigen Receptor Specificity | 1 | 2017 | 93 | 0.18 | Why? |
| Hydroxybenzoates | 1 | 2017 | 25 | 0.18 | Why? |
| Personality Assessment | 1 | 2017 | 11 | 0.18 | Why? |
| Deubiquitinating Enzymes | 1 | 2018 | 55 | 0.18 | Why? |
| Photoperiod | 1 | 2017 | 41 | 0.18 | Why? |
| Naphthalenes | 1 | 2018 | 94 | 0.18 | Why? |
| Cytogenetic Analysis | 1 | 2017 | 21 | 0.18 | Why? |
| Core Binding Factor beta Subunit | 1 | 2017 | 4 | 0.18 | Why? |
| Precursor Cells, B-Lymphoid | 1 | 2017 | 12 | 0.18 | Why? |
| Sirolimus | 2 | 2017 | 240 | 0.18 | Why? |
| Inhibitory Concentration 50 | 2 | 2018 | 907 | 0.18 | Why? |
| Pancreatic Elastase | 1 | 2017 | 41 | 0.18 | Why? |
| Corpus Striatum | 1 | 2018 | 49 | 0.18 | Why? |
| Rhytidoplasty | 1 | 2017 | 21 | 0.18 | Why? |
| Oleic Acid | 1 | 2017 | 43 | 0.18 | Why? |
| Receptors, Somatomedin | 1 | 2017 | 7 | 0.18 | Why? |
| Wheelchairs | 1 | 2017 | 22 | 0.18 | Why? |
| Pyrethrins | 1 | 2017 | 28 | 0.18 | Why? |
| DNA, Neoplasm | 1 | 2017 | 56 | 0.18 | Why? |
| Crops, Agricultural | 1 | 2018 | 88 | 0.18 | Why? |
| Hypereosinophilic Syndrome | 1 | 2018 | 33 | 0.18 | Why? |
| Glomerulonephritis, IGA | 1 | 2019 | 115 | 0.18 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2019 | 1454 | 0.18 | Why? |
| Nacre | 1 | 2017 | 2 | 0.18 | Why? |
| Chromosomes, Human, Pair 8 | 1 | 2017 | 25 | 0.18 | Why? |
| Thymol | 1 | 2017 | 5 | 0.18 | Why? |
| Osmolar Concentration | 1 | 2017 | 86 | 0.18 | Why? |
| Hepatic Veins | 1 | 2018 | 54 | 0.18 | Why? |
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2017 | 5 | 0.18 | Why? |
| Ependymoglial Cells | 1 | 2017 | 3 | 0.18 | Why? |
| Solute Carrier Family 12, Member 1 | 1 | 2017 | 1 | 0.18 | Why? |
| Carboxylesterase | 1 | 2017 | 22 | 0.18 | Why? |
| Feasibility Studies | 5 | 2018 | 3467 | 0.18 | Why? |
| Muscle Proteins | 1 | 2017 | 64 | 0.18 | Why? |
| Bone Screws | 1 | 2017 | 30 | 0.18 | Why? |
| Receptor, Adenosine A2B | 1 | 2017 | 1 | 0.18 | Why? |
| Zirconium | 1 | 2017 | 10 | 0.18 | Why? |
| Hip Prosthesis | 1 | 2018 | 54 | 0.18 | Why? |
| Soil Pollutants | 1 | 2018 | 57 | 0.18 | Why? |
| Chromosome Mapping | 1 | 2018 | 178 | 0.18 | Why? |
| Cryotherapy | 1 | 2017 | 31 | 0.18 | Why? |
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2017 | 3 | 0.18 | Why? |
| Leptospira interrogans | 1 | 2017 | 9 | 0.18 | Why? |
| Fluoroscopy | 1 | 2018 | 140 | 0.18 | Why? |
| Dental Pulp | 1 | 2018 | 48 | 0.18 | Why? |
| Hematoma, Epidural, Spinal | 1 | 2017 | 7 | 0.18 | Why? |
| Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 5 | 0.17 | Why? |
| Bone Diseases, Metabolic | 1 | 2018 | 64 | 0.17 | Why? |
| Thiophenes | 1 | 2018 | 78 | 0.17 | Why? |
| Pseudogenes | 1 | 2017 | 61 | 0.17 | Why? |
| Matrix Metalloproteinase 13 | 4 | 2019 | 11 | 0.17 | Why? |
| Cell Dedifferentiation | 1 | 2017 | 7 | 0.17 | Why? |
| Potassium Channels, Tandem Pore Domain | 1 | 2017 | 11 | 0.17 | Why? |
| Polygonum | 1 | 2017 | 1 | 0.17 | Why? |
| Sperm Injections, Intracytoplasmic | 1 | 2017 | 87 | 0.17 | Why? |
| Histone-Lysine N-Methyltransferase | 1 | 2018 | 82 | 0.17 | Why? |
| Glycosaminoglycans | 1 | 2018 | 140 | 0.17 | Why? |
| Ligustrum | 1 | 2016 | 1 | 0.17 | Why? |
| Receptors, Glucocorticoid | 1 | 2018 | 118 | 0.17 | Why? |
| Cytotoxins | 1 | 2017 | 57 | 0.17 | Why? |
| Quinones | 1 | 2017 | 43 | 0.17 | Why? |
| Cholagogues and Choleretics | 1 | 2017 | 11 | 0.17 | Why? |
| Penaeidae | 1 | 2017 | 13 | 0.17 | Why? |
| Hemangioma | 1 | 2018 | 62 | 0.17 | Why? |
| Genes, Neoplasm | 2 | 2018 | 26 | 0.17 | Why? |
| Regression Analysis | 3 | 2020 | 2484 | 0.17 | Why? |
| Immobilized Proteins | 1 | 2017 | 47 | 0.17 | Why? |
| Receptors, Lysosphingolipid | 1 | 2017 | 25 | 0.17 | Why? |
| Fusion Proteins, bcr-abl | 1 | 2017 | 20 | 0.17 | Why? |
| Nerve Tissue | 1 | 2017 | 10 | 0.17 | Why? |
| Renal Elimination | 1 | 2017 | 62 | 0.17 | Why? |
| Embryo Implantation | 1 | 2017 | 59 | 0.17 | Why? |
| Uric Acid | 2 | 2017 | 285 | 0.17 | Why? |
| Cerebrum | 1 | 2017 | 17 | 0.17 | Why? |
| Visual Acuity | 3 | 2019 | 790 | 0.17 | Why? |
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2018 | 76 | 0.17 | Why? |
| Salivary alpha-Amylases | 1 | 2017 | 16 | 0.17 | Why? |
| Betaine | 1 | 2017 | 16 | 0.17 | Why? |
| Biodegradation, Environmental | 1 | 2017 | 52 | 0.17 | Why? |
| Estrogen Receptor beta | 1 | 2017 | 14 | 0.17 | Why? |
| Body Weight | 3 | 2019 | 1074 | 0.17 | Why? |
| Collagen Type I | 1 | 2017 | 56 | 0.17 | Why? |
| Protein Kinases | 1 | 2018 | 93 | 0.17 | Why? |
| Interleukin-1alpha | 1 | 2017 | 42 | 0.17 | Why? |
| Facial Nerve | 1 | 2017 | 83 | 0.17 | Why? |
| Naphthyridines | 1 | 2017 | 48 | 0.17 | Why? |
| Extracellular Fluid | 1 | 2017 | 19 | 0.17 | Why? |
| Multidetector Computed Tomography | 2 | 2018 | 307 | 0.17 | Why? |
| Tyrosine | 1 | 2017 | 66 | 0.17 | Why? |
| Bone Substitutes | 1 | 2017 | 16 | 0.17 | Why? |
| Introns | 1 | 2017 | 112 | 0.17 | Why? |
| Sphingolipids | 1 | 2018 | 59 | 0.17 | Why? |
| Fabaceae | 1 | 2017 | 39 | 0.17 | Why? |
| Spectroscopy, Near-Infrared | 1 | 2018 | 137 | 0.17 | Why? |
| Turtles | 1 | 2017 | 17 | 0.17 | Why? |
| Hemocytes | 1 | 2017 | 19 | 0.17 | Why? |
| Luminescent Proteins | 1 | 2017 | 142 | 0.17 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.17 | Why? |
| Biofilms | 2 | 2018 | 304 | 0.17 | Why? |
| Thyroid Nodule | 1 | 2018 | 70 | 0.17 | Why? |
| Methazolamide | 1 | 2016 | 2 | 0.17 | Why? |
| Solubility | 1 | 2018 | 382 | 0.17 | Why? |
| Suture Techniques | 1 | 2019 | 138 | 0.17 | Why? |
| Genome, Plant | 1 | 2017 | 41 | 0.17 | Why? |
| Diphosphonates | 1 | 2018 | 121 | 0.17 | Why? |
| Bone Plates | 1 | 2017 | 26 | 0.17 | Why? |
| Kaempferols | 1 | 2017 | 33 | 0.17 | Why? |
| Lactobacillus casei | 1 | 2016 | 24 | 0.17 | Why? |
| Anterior Cruciate Ligament Reconstruction | 1 | 2017 | 24 | 0.17 | Why? |
| Glycation End Products, Advanced | 1 | 2018 | 72 | 0.17 | Why? |
| Receptors, CCR2 | 1 | 2017 | 103 | 0.17 | Why? |
| Gene Expression Regulation, Bacterial | 1 | 2018 | 143 | 0.17 | Why? |
| Staphylococcus aureus | 3 | 2018 | 844 | 0.17 | Why? |
| Gene Expression Regulation, Developmental | 1 | 2018 | 159 | 0.17 | Why? |
| Influenza A Virus, H9N2 Subtype | 1 | 2017 | 61 | 0.17 | Why? |
| Ranibizumab | 1 | 2018 | 103 | 0.17 | Why? |
| alpha-Fetoproteins | 1 | 2017 | 72 | 0.17 | Why? |
| Zonula Occludens-1 Protein | 1 | 2017 | 54 | 0.17 | Why? |
| Meningeal Carcinomatosis | 1 | 2017 | 15 | 0.17 | Why? |
| Intestinal Neoplasms | 1 | 2017 | 42 | 0.17 | Why? |
| Functional Neuroimaging | 1 | 2017 | 86 | 0.17 | Why? |
| Potassium Channels, Inwardly Rectifying | 1 | 2017 | 29 | 0.17 | Why? |
| Microwaves | 1 | 2018 | 88 | 0.17 | Why? |
| Ovarian Reserve | 1 | 2017 | 45 | 0.17 | Why? |
| Emodin | 1 | 2017 | 32 | 0.17 | Why? |
| Cryosurgery | 1 | 2018 | 57 | 0.17 | Why? |
| Cell Fusion | 1 | 2019 | 400 | 0.17 | Why? |
| Altitude | 2 | 2018 | 311 | 0.17 | Why? |
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 100 | 0.17 | Why? |
| Edetic Acid | 1 | 2017 | 85 | 0.17 | Why? |
| Nucleotide Motifs | 1 | 2017 | 58 | 0.17 | Why? |
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 54 | 0.17 | Why? |
| Appendicitis | 2 | 2018 | 946 | 0.17 | Why? |
| Phacoemulsification | 1 | 2019 | 102 | 0.17 | Why? |
| Hypertension, Renovascular | 1 | 2016 | 14 | 0.17 | Why? |
| Cell Self Renewal | 1 | 2017 | 55 | 0.17 | Why? |
| Rejuvenation | 1 | 2017 | 41 | 0.17 | Why? |
| Benzylisoquinolines | 1 | 2017 | 64 | 0.17 | Why? |
| Adaptation, Biological | 1 | 2018 | 179 | 0.17 | Why? |
| Iodine Radioisotopes | 1 | 2018 | 124 | 0.17 | Why? |
| Tomography Scanners, X-Ray Computed | 1 | 2017 | 98 | 0.17 | Why? |
| Cholesterol, HDL | 2 | 2017 | 439 | 0.17 | Why? |
| Circovirus | 1 | 2017 | 53 | 0.17 | Why? |
| Tibial Fractures | 1 | 2017 | 32 | 0.17 | Why? |
| Ultrasonics | 1 | 2016 | 41 | 0.17 | Why? |
| Methadone | 1 | 2020 | 296 | 0.17 | Why? |
| Gene Expression Regulation, Plant | 1 | 2017 | 110 | 0.17 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.17 | Why? |
| Depression | 6 | 2019 | 14116 | 0.17 | Why? |
| Taxoids | 1 | 2016 | 45 | 0.17 | Why? |
| Simplexvirus | 1 | 2017 | 124 | 0.17 | Why? |
| DNA, Viral | 2 | 2018 | 2521 | 0.17 | Why? |
| Femur | 1 | 2017 | 100 | 0.17 | Why? |
| Methyl-CpG-Binding Protein 2 | 1 | 2016 | 12 | 0.17 | Why? |
| Solitary Pulmonary Nodule | 1 | 2018 | 83 | 0.17 | Why? |
| Membranes, Artificial | 1 | 2019 | 175 | 0.17 | Why? |
| Retinal Neovascularization | 1 | 2016 | 29 | 0.17 | Why? |
| Gallstones | 1 | 2017 | 64 | 0.17 | Why? |
| In Vitro Techniques | 2 | 2018 | 1027 | 0.17 | Why? |
| Antigens, CD20 | 1 | 2017 | 105 | 0.17 | Why? |
| Anesthetics, Intravenous | 1 | 2018 | 98 | 0.17 | Why? |
| Endopeptidases | 1 | 2018 | 228 | 0.17 | Why? |
| Amygdala | 1 | 2017 | 42 | 0.17 | Why? |
| Lysosomes | 2 | 2017 | 416 | 0.17 | Why? |
| Cervical Intraepithelial Neoplasia | 1 | 2018 | 114 | 0.17 | Why? |
| Isoflavones | 1 | 2017 | 52 | 0.17 | Why? |
| Rett Syndrome | 1 | 2016 | 9 | 0.17 | Why? |
| Uremia | 1 | 2017 | 50 | 0.17 | Why? |
| Insect Vectors | 1 | 2019 | 227 | 0.17 | Why? |
| Gait Disorders, Neurologic | 1 | 2017 | 64 | 0.17 | Why? |
| Pleural Neoplasms | 1 | 2017 | 71 | 0.17 | Why? |
| Pyrans | 1 | 2016 | 56 | 0.17 | Why? |
| Antilymphocyte Serum | 1 | 2017 | 80 | 0.17 | Why? |
| Bronchiolitis Obliterans | 1 | 2017 | 86 | 0.17 | Why? |
| Cost of Illness | 2 | 2018 | 1903 | 0.17 | Why? |
| Cell Wall | 1 | 2016 | 62 | 0.16 | Why? |
| Acetamides | 1 | 2018 | 141 | 0.16 | Why? |
| Myofibroblasts | 1 | 2017 | 61 | 0.16 | Why? |
| Antigen-Presenting Cells | 1 | 2017 | 206 | 0.16 | Why? |
| Herpesvirus 8, Human | 1 | 2018 | 97 | 0.16 | Why? |
| Renal Artery Obstruction | 1 | 2016 | 27 | 0.16 | Why? |
| Mutagenesis, Insertional | 1 | 2017 | 92 | 0.16 | Why? |
| Radiation Tolerance | 1 | 2016 | 25 | 0.16 | Why? |
| Ketoglutaric Acids | 1 | 2016 | 3 | 0.16 | Why? |
| Muscle, Smooth, Vascular | 1 | 2017 | 86 | 0.16 | Why? |
| Interleukin-12 | 1 | 2018 | 156 | 0.16 | Why? |
| Cell Size | 1 | 2017 | 106 | 0.16 | Why? |
| Glasgow Coma Scale | 1 | 2017 | 249 | 0.16 | Why? |
| Pollen | 1 | 2017 | 137 | 0.16 | Why? |
| Lymph Nodes | 2 | 2017 | 1060 | 0.16 | Why? |
| Optical Imaging | 1 | 2018 | 197 | 0.16 | Why? |
| Macrophages, Alveolar | 2 | 2018 | 668 | 0.16 | Why? |
| Vanadium Compounds | 1 | 2016 | 6 | 0.16 | Why? |
| Intracranial Arteriosclerosis | 1 | 2017 | 46 | 0.16 | Why? |
| GABAergic Neurons | 1 | 2016 | 20 | 0.16 | Why? |
| Plasminogen Activator Inhibitor 1 | 1 | 2018 | 162 | 0.16 | Why? |
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2018 | 82 | 0.16 | Why? |
| Sesquiterpenes | 1 | 2017 | 77 | 0.16 | Why? |
| Surgery, Computer-Assisted | 1 | 2019 | 183 | 0.16 | Why? |
| Minor Histocompatibility Antigens | 1 | 2017 | 56 | 0.16 | Why? |
| Benzofurans | 1 | 2018 | 91 | 0.16 | Why? |
| Perylene | 1 | 2016 | 34 | 0.16 | Why? |
| Predictive Value of Tests | 8 | 2018 | 9537 | 0.16 | Why? |
| Reference Standards | 2 | 2018 | 1163 | 0.16 | Why? |
| 14-3-3 Proteins | 1 | 2017 | 55 | 0.16 | Why? |
| Memory, Short-Term | 1 | 2017 | 137 | 0.16 | Why? |
| Clone Cells | 1 | 2017 | 312 | 0.16 | Why? |
| Ibuprofen | 1 | 2019 | 156 | 0.16 | Why? |
| Interleukin-2 Receptor alpha Subunit | 1 | 2018 | 234 | 0.16 | Why? |
| Muscle, Skeletal | 3 | 2019 | 915 | 0.16 | Why? |
| Time Factors | 17 | 2018 | 31397 | 0.16 | Why? |
| Mediastinal Neoplasms | 1 | 2017 | 57 | 0.16 | Why? |
| Acclimatization | 1 | 2017 | 69 | 0.16 | Why? |
| Proteasome Endopeptidase Complex | 1 | 2018 | 249 | 0.16 | Why? |
| Spheroids, Cellular | 1 | 2017 | 124 | 0.16 | Why? |
| Patch-Clamp Techniques | 2 | 2018 | 49 | 0.16 | Why? |
| Mesothelioma | 1 | 2017 | 76 | 0.16 | Why? |
| Free Tissue Flaps | 1 | 2017 | 86 | 0.16 | Why? |
| Reading | 1 | 2017 | 80 | 0.16 | Why? |
| Double-Blind Method | 2 | 2018 | 5988 | 0.16 | Why? |
| Lung | 6 | 2020 | 31049 | 0.16 | Why? |
| Receptors, Nicotinic | 1 | 2017 | 81 | 0.16 | Why? |
| Energy Metabolism | 2 | 2019 | 451 | 0.16 | Why? |
| DNA, Mitochondrial | 1 | 2018 | 163 | 0.16 | Why? |
| Furans | 1 | 2017 | 156 | 0.16 | Why? |
| Femoral Artery | 1 | 2018 | 213 | 0.16 | Why? |
| Triiodothyronine | 1 | 2018 | 201 | 0.16 | Why? |
| Quantum Dots | 1 | 2018 | 129 | 0.16 | Why? |
| Phytotherapy | 3 | 2019 | 743 | 0.16 | Why? |
| Vitiligo | 1 | 2017 | 76 | 0.16 | Why? |
| Capsid | 1 | 2018 | 197 | 0.16 | Why? |
| Membrane Transport Proteins | 1 | 2018 | 152 | 0.16 | Why? |
| Lupus Nephritis | 1 | 2017 | 113 | 0.16 | Why? |
| Negative-Pressure Wound Therapy | 1 | 2017 | 66 | 0.16 | Why? |
| Copper | 2 | 2017 | 288 | 0.16 | Why? |
| Electrochemistry | 1 | 2016 | 26 | 0.16 | Why? |
| Health Surveys | 2 | 2018 | 2841 | 0.16 | Why? |
| Pancreatectomy | 1 | 2017 | 87 | 0.16 | Why? |
| Stents | 3 | 2019 | 916 | 0.16 | Why? |
| Fluorocarbons | 2 | 2017 | 102 | 0.16 | Why? |
| Gene Deletion | 1 | 2018 | 430 | 0.16 | Why? |
| Cysts | 1 | 2018 | 94 | 0.16 | Why? |
| Angioplasty, Balloon | 1 | 2016 | 66 | 0.16 | Why? |
| Croatia | 1 | 2018 | 360 | 0.16 | Why? |
| Chromatin | 1 | 2017 | 107 | 0.16 | Why? |
| Dabigatran | 1 | 2018 | 204 | 0.16 | Why? |
| Bone Remodeling | 1 | 2016 | 59 | 0.16 | Why? |
| Pericytes | 1 | 2017 | 108 | 0.16 | Why? |
| Lymphoma, B-Cell | 1 | 2018 | 166 | 0.16 | Why? |
| Head | 1 | 2018 | 206 | 0.16 | Why? |
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2017 | 98 | 0.16 | Why? |
| Levofloxacin | 1 | 2017 | 115 | 0.16 | Why? |
| In Situ Hybridization, Fluorescence | 4 | 2017 | 207 | 0.16 | Why? |
| Cerebral Arteries | 1 | 2017 | 90 | 0.16 | Why? |
| Carrageenan | 1 | 2017 | 123 | 0.16 | Why? |
| Middle Cerebral Artery | 1 | 2017 | 128 | 0.16 | Why? |
| Environmental Exposure | 2 | 2017 | 1558 | 0.16 | Why? |
| Intraocular Pressure | 1 | 2019 | 276 | 0.16 | Why? |
| Models, Chemical | 1 | 2018 | 332 | 0.16 | Why? |
| Respiratory Function Tests | 3 | 2018 | 1755 | 0.16 | Why? |
| Spectroscopy, Fourier Transform Infrared | 1 | 2017 | 207 | 0.16 | Why? |
| Caspase 3 | 4 | 2018 | 218 | 0.16 | Why? |
| Blood Vessels | 1 | 2018 | 228 | 0.16 | Why? |
| Fatty Acids | 1 | 2017 | 238 | 0.16 | Why? |
| Artifacts | 1 | 2018 | 250 | 0.16 | Why? |
| Fractional Flow Reserve, Myocardial | 1 | 2018 | 173 | 0.16 | Why? |
| Lymphoma, Mantle-Cell | 1 | 2016 | 109 | 0.16 | Why? |
| Neoplasms, Second Primary | 1 | 2017 | 100 | 0.16 | Why? |
| Lipopeptides | 1 | 2019 | 229 | 0.16 | Why? |
| Receptor, Angiotensin, Type 1 | 1 | 2017 | 160 | 0.16 | Why? |
| Selection Bias | 1 | 2017 | 201 | 0.16 | Why? |
| Drug Resistance, Multiple | 1 | 2017 | 156 | 0.16 | Why? |
| Age Distribution | 4 | 2018 | 3567 | 0.16 | Why? |
| Pravastatin | 1 | 2015 | 10 | 0.15 | Why? |
| Dendritic Cells | 2 | 2018 | 1330 | 0.15 | Why? |
| Tobacco Smoke Pollution | 1 | 2019 | 181 | 0.15 | Why? |
| Genes, Reporter | 1 | 2017 | 472 | 0.15 | Why? |
| Dilatation | 1 | 2017 | 181 | 0.15 | Why? |
| Interleukins | 2 | 2019 | 762 | 0.15 | Why? |
| Self-Assessment | 1 | 2017 | 165 | 0.15 | Why? |
| Cancer Vaccines | 1 | 2017 | 136 | 0.15 | Why? |
| Antigens, Differentiation | 1 | 2017 | 172 | 0.15 | Why? |
| Calcitriol | 1 | 2016 | 84 | 0.15 | Why? |
| Surveys and Questionnaires | 9 | 2019 | 43792 | 0.15 | Why? |
| Clinical Audit | 1 | 2017 | 204 | 0.15 | Why? |
| Myocardial Reperfusion Injury | 1 | 2017 | 129 | 0.15 | Why? |
| Connexins | 1 | 2015 | 30 | 0.15 | Why? |
| Costs and Cost Analysis | 2 | 2018 | 694 | 0.15 | Why? |
| Leptospirosis | 1 | 2017 | 103 | 0.15 | Why? |
| Plasmids | 2 | 2017 | 840 | 0.15 | Why? |
| Cold Temperature | 1 | 2017 | 260 | 0.15 | Why? |
| Personnel Turnover | 1 | 2017 | 121 | 0.15 | Why? |
| Antithrombins | 1 | 2019 | 353 | 0.15 | Why? |
| Surgical Flaps | 1 | 2018 | 188 | 0.15 | Why? |
| Portal Vein | 1 | 2018 | 193 | 0.15 | Why? |
| Foramen Ovale, Patent | 1 | 2018 | 153 | 0.15 | Why? |
| Bone Density Conservation Agents | 1 | 2018 | 209 | 0.15 | Why? |
| Sleep | 3 | 2018 | 2695 | 0.15 | Why? |
| Cognitive Dysfunction | 2 | 2018 | 1389 | 0.15 | Why? |
| Prevalence | 8 | 2018 | 25773 | 0.15 | Why? |
| Child | 20 | 2019 | 70012 | 0.15 | Why? |
| Serotonin Uptake Inhibitors | 1 | 2017 | 149 | 0.15 | Why? |
| Carotid Intima-Media Thickness | 1 | 2017 | 179 | 0.15 | Why? |
| Blood-Brain Barrier | 2 | 2017 | 531 | 0.15 | Why? |
| Hallucinations | 1 | 2017 | 122 | 0.15 | Why? |
| Laparotomy | 1 | 2018 | 241 | 0.15 | Why? |
| Biostatistics | 1 | 2017 | 116 | 0.15 | Why? |
| Polycystic Kidney, Autosomal Dominant | 1 | 2015 | 31 | 0.15 | Why? |
| CHO Cells | 4 | 2019 | 831 | 0.15 | Why? |
| Whiplash Injuries | 1 | 2015 | 6 | 0.15 | Why? |
| Executive Function | 1 | 2017 | 173 | 0.15 | Why? |
| Fruit | 1 | 2018 | 313 | 0.15 | Why? |
| Respiratory Physiological Phenomena | 1 | 2017 | 157 | 0.15 | Why? |
| Ion Channels | 1 | 2017 | 167 | 0.15 | Why? |
| Mucocutaneous Lymph Node Syndrome | 2 | 2018 | 1645 | 0.15 | Why? |
| Radionuclide Imaging | 1 | 2017 | 184 | 0.15 | Why? |
| Body Mass Index | 3 | 2017 | 4306 | 0.15 | Why? |
| Brain Infarction | 1 | 2017 | 129 | 0.15 | Why? |
| Th1 Cells | 2 | 2018 | 1228 | 0.15 | Why? |
| Gyrus Cinguli | 1 | 2015 | 28 | 0.15 | Why? |
| Drug Resistant Epilepsy | 1 | 2017 | 106 | 0.15 | Why? |
| Receptors, KIR | 1 | 2017 | 167 | 0.15 | Why? |
| Antigens | 1 | 2017 | 267 | 0.15 | Why? |
| Hepatitis | 1 | 2018 | 160 | 0.15 | Why? |
| Aortic Aneurysm | 1 | 2017 | 121 | 0.15 | Why? |
| Influenza A Virus, H5N1 Subtype | 1 | 2019 | 492 | 0.15 | Why? |
| Oxygen | 3 | 2018 | 3715 | 0.15 | Why? |
| Mice, Transgenic | 4 | 2018 | 2739 | 0.15 | Why? |
| Erythrocyte Indices | 1 | 2017 | 207 | 0.15 | Why? |
| Hearing Loss, Sensorineural | 1 | 2018 | 159 | 0.15 | Why? |
| Nanofibers | 1 | 2017 | 143 | 0.15 | Why? |
| Propofol | 1 | 2018 | 172 | 0.15 | Why? |
| Receptor, Angiotensin, Type 2 | 1 | 2017 | 190 | 0.15 | Why? |
| Neurosurgical Procedures | 2 | 2017 | 1738 | 0.15 | Why? |
| Esophageal and Gastric Varices | 1 | 2017 | 117 | 0.15 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 347 | 0.15 | Why? |
| Blood Glucose | 3 | 2019 | 3642 | 0.15 | Why? |
| Cerebrospinal Fluid | 1 | 2017 | 234 | 0.15 | Why? |
| Rhizome | 1 | 2014 | 19 | 0.15 | Why? |
| Toll-Like Receptor 9 | 1 | 2015 | 72 | 0.15 | Why? |
| Protein Structure, Secondary | 1 | 2019 | 1077 | 0.15 | Why? |
| Antimetabolites, Antineoplastic | 2 | 2012 | 99 | 0.15 | Why? |
| Anesthetics, Local | 1 | 2018 | 205 | 0.14 | Why? |
| Vasodilation | 1 | 2017 | 258 | 0.14 | Why? |
| Autistic Disorder | 1 | 2019 | 253 | 0.14 | Why? |
| Parietal Lobe | 1 | 2015 | 29 | 0.14 | Why? |
| Reaction Time | 1 | 2015 | 96 | 0.14 | Why? |
| Sumoylation | 1 | 2014 | 21 | 0.14 | Why? |
| Atrial Fibrillation | 3 | 2018 | 2320 | 0.14 | Why? |
| Mammary Glands, Animal | 1 | 2014 | 9 | 0.14 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2019 | 511 | 0.14 | Why? |
| Esters | 1 | 2017 | 300 | 0.14 | Why? |
| Transcriptome | 2 | 2019 | 3466 | 0.14 | Why? |
| Human Embryonic Stem Cells | 1 | 2017 | 199 | 0.14 | Why? |
| Membrane Fusion | 1 | 2019 | 713 | 0.14 | Why? |
| Graphite | 1 | 2019 | 318 | 0.14 | Why? |
| Estradiol | 1 | 2017 | 250 | 0.14 | Why? |
| Kv1.2 Potassium Channel | 1 | 2014 | 2 | 0.14 | Why? |
| Neurons, Afferent | 1 | 2014 | 3 | 0.14 | Why? |
| Panax | 1 | 2014 | 39 | 0.14 | Why? |
| Foreign Bodies | 1 | 2018 | 171 | 0.14 | Why? |
| Vascular Stiffness | 1 | 2018 | 264 | 0.14 | Why? |
| Glomerulonephritis | 1 | 2018 | 226 | 0.14 | Why? |
| Drug Carriers | 2 | 2020 | 590 | 0.14 | Why? |
| Cross-Over Studies | 1 | 2018 | 867 | 0.14 | Why? |
| Vancomycin | 1 | 2018 | 328 | 0.14 | Why? |
| Viral Vaccines | 3 | 2020 | 7560 | 0.14 | Why? |
| Computational Biology | 3 | 2019 | 4514 | 0.14 | Why? |
| Demyelinating Diseases | 1 | 2017 | 224 | 0.14 | Why? |
| Peripheral Nervous System Diseases | 1 | 2017 | 193 | 0.14 | Why? |
| Thrombin | 1 | 2017 | 325 | 0.14 | Why? |
| Coronary Stenosis | 1 | 2018 | 273 | 0.14 | Why? |
| Glomerular Filtration Rate | 2 | 2017 | 1262 | 0.14 | Why? |
| Nanotubes | 1 | 2015 | 72 | 0.14 | Why? |
| Victoria | 1 | 2017 | 607 | 0.14 | Why? |
| Fecal Microbiota Transplantation | 1 | 2019 | 372 | 0.14 | Why? |
| Survival Analysis | 8 | 2020 | 7592 | 0.14 | Why? |
| Cardiomyopathy, Dilated | 1 | 2017 | 251 | 0.14 | Why? |
| Infertility | 1 | 2018 | 247 | 0.14 | Why? |
| Triglycerides | 1 | 2017 | 478 | 0.14 | Why? |
| Insurance, Health | 2 | 2018 | 634 | 0.14 | Why? |
| Drug Therapy | 1 | 2017 | 280 | 0.14 | Why? |
| Janus Kinase Inhibitors | 1 | 2020 | 682 | 0.14 | Why? |
| Brain Edema | 1 | 2016 | 224 | 0.14 | Why? |
| Phylogeny | 6 | 2019 | 13341 | 0.14 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2017 | 1510 | 0.14 | Why? |
| Spermatozoa | 1 | 2017 | 244 | 0.14 | Why? |
| Thalidomide | 1 | 2017 | 247 | 0.14 | Why? |
| Germinal Center | 1 | 2017 | 332 | 0.14 | Why? |
| Cholecystitis, Acute | 1 | 2017 | 234 | 0.14 | Why? |
| Fetus | 1 | 2018 | 484 | 0.14 | Why? |
| Water Pollutants, Chemical | 2 | 2017 | 410 | 0.14 | Why? |
| Autoantibodies | 3 | 2021 | 2094 | 0.14 | Why? |
| Arrhythmias, Cardiac | 2 | 2018 | 2510 | 0.14 | Why? |
| Neurologic Examination | 1 | 2017 | 428 | 0.13 | Why? |
| Carcinoma | 1 | 2017 | 256 | 0.13 | Why? |
| Methane | 1 | 2013 | 26 | 0.13 | Why? |
| Sex Distribution | 2 | 2018 | 2083 | 0.13 | Why? |
| Interleukin-6 | 5 | 2019 | 7522 | 0.13 | Why? |
| Warfarin | 1 | 2018 | 402 | 0.13 | Why? |
| Drainage | 1 | 2017 | 414 | 0.13 | Why? |
| Membrane Potential, Mitochondrial | 3 | 2018 | 102 | 0.13 | Why? |
| Alanine Transaminase | 2 | 2017 | 1329 | 0.13 | Why? |
| Action Potentials | 2 | 2018 | 368 | 0.13 | Why? |
| Acetaminophen | 1 | 2017 | 326 | 0.13 | Why? |
| Gastrointestinal Neoplasms | 1 | 2019 | 392 | 0.13 | Why? |
| Urine | 1 | 2017 | 469 | 0.13 | Why? |
| Pyrroles | 1 | 2017 | 292 | 0.13 | Why? |
| Sensitivity and Specificity | 9 | 2018 | 22971 | 0.13 | Why? |
| Receptors, G-Protein-Coupled | 1 | 2017 | 309 | 0.13 | Why? |
| World Health Organization | 2 | 2017 | 4213 | 0.13 | Why? |
| Hematoma | 1 | 2017 | 305 | 0.13 | Why? |
| Neuroendocrine Tumors | 1 | 2017 | 241 | 0.13 | Why? |
| Drug Synergism | 1 | 2017 | 833 | 0.13 | Why? |
| Genetic Testing | 1 | 2017 | 395 | 0.13 | Why? |
| Species Specificity | 1 | 2018 | 1356 | 0.13 | Why? |
| Antibodies, Monoclonal | 3 | 2018 | 8041 | 0.13 | Why? |
| Protons | 1 | 2013 | 64 | 0.13 | Why? |
| Plaque, Atherosclerotic | 1 | 2018 | 423 | 0.13 | Why? |
| Waste Disposal, Fluid | 1 | 2013 | 60 | 0.13 | Why? |
| Proteolysis | 1 | 2018 | 751 | 0.13 | Why? |
| Histocompatibility Antigens Class I | 1 | 2018 | 624 | 0.13 | Why? |
| Vaccination | 2 | 2020 | 19050 | 0.13 | Why? |
| Microbubbles | 1 | 2013 | 40 | 0.13 | Why? |
| Facial Paralysis | 1 | 2017 | 231 | 0.13 | Why? |
| Cerebrovascular Circulation | 1 | 2017 | 340 | 0.13 | Why? |
| RNA-Binding Proteins | 2 | 2018 | 1022 | 0.13 | Why? |
| Guanylate Cyclase | 1 | 2012 | 10 | 0.13 | Why? |
| Radiologists | 1 | 2020 | 873 | 0.13 | Why? |
| Virus Replication | 4 | 2019 | 14331 | 0.13 | Why? |
| Brain Mapping | 1 | 2015 | 228 | 0.13 | Why? |
| Frontal Lobe | 1 | 2015 | 191 | 0.13 | Why? |
| Physicians, Primary Care | 1 | 2017 | 298 | 0.13 | Why? |
| Equipment Failure Analysis | 2 | 2010 | 94 | 0.13 | Why? |
| Child Development | 1 | 2017 | 352 | 0.13 | Why? |
| Bronchiectasis | 1 | 2018 | 312 | 0.13 | Why? |
| Coculture Techniques | 3 | 2019 | 258 | 0.13 | Why? |
| Protein Interaction Maps | 2 | 2018 | 1333 | 0.13 | Why? |
| Amino Acids | 1 | 2017 | 552 | 0.13 | Why? |
| Electroencephalography | 2 | 2018 | 1242 | 0.13 | Why? |
| Thyroid Gland | 1 | 2018 | 516 | 0.13 | Why? |
| Sex Factors | 4 | 2018 | 11014 | 0.13 | Why? |
| Status Epilepticus | 1 | 2017 | 303 | 0.13 | Why? |
| Cardiovascular Diseases | 5 | 2018 | 11497 | 0.13 | Why? |
| Liposomes | 2 | 2012 | 334 | 0.12 | Why? |
| Drug Liberation | 3 | 2019 | 141 | 0.12 | Why? |
| Anesthesia, General | 1 | 2018 | 470 | 0.12 | Why? |
| Cholesterol | 1 | 2017 | 660 | 0.12 | Why? |
| Real-Time Polymerase Chain Reaction | 7 | 2018 | 11367 | 0.12 | Why? |
| Poultry Diseases | 1 | 2018 | 588 | 0.12 | Why? |
| Chickens | 1 | 2018 | 1010 | 0.12 | Why? |
| Thyroid Neoplasms | 1 | 2018 | 422 | 0.12 | Why? |
| Medicaid | 1 | 2018 | 492 | 0.12 | Why? |
| Biotransformation | 1 | 2012 | 74 | 0.12 | Why? |
| Acute Pain | 1 | 2014 | 73 | 0.12 | Why? |
| Antidepressive Agents | 1 | 2018 | 509 | 0.12 | Why? |
| N-Acetylgalactosaminyltransferases | 1 | 2012 | 3 | 0.12 | Why? |
| Dermatologic Agents | 1 | 2019 | 489 | 0.12 | Why? |
| Adenoviridae | 3 | 2020 | 1151 | 0.12 | Why? |
| Hypnotics and Sedatives | 1 | 2018 | 624 | 0.12 | Why? |
| CARD Signaling Adaptor Proteins | 1 | 2012 | 70 | 0.12 | Why? |
| Coronary Artery Bypass | 1 | 2019 | 629 | 0.12 | Why? |
| Sequence Deletion | 1 | 2017 | 674 | 0.12 | Why? |
| Microscopy, Electron, Scanning | 3 | 2018 | 221 | 0.12 | Why? |
| G(M2) Ganglioside | 1 | 2011 | 1 | 0.12 | Why? |
| Limit of Detection | 2 | 2017 | 2698 | 0.12 | Why? |
| Airway Extubation | 1 | 2018 | 403 | 0.12 | Why? |
| Myocytes, Cardiac | 1 | 2019 | 804 | 0.12 | Why? |
| Antiviral Agents | 3 | 2021 | 41703 | 0.12 | Why? |
| Arthroplasty, Replacement, Hip | 1 | 2018 | 403 | 0.12 | Why? |
| Genetics, Population | 1 | 2012 | 162 | 0.12 | Why? |
| C-Reactive Protein | 3 | 2017 | 7972 | 0.12 | Why? |
| Antigens, CD | 1 | 2018 | 984 | 0.12 | Why? |
| Ethanol | 1 | 2018 | 533 | 0.12 | Why? |
| Drug Hypersensitivity | 1 | 2018 | 401 | 0.12 | Why? |
| Quality of Life | 3 | 2018 | 9820 | 0.12 | Why? |
| Ultrasonography, Interventional | 1 | 2017 | 560 | 0.12 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2017 | 13720 | 0.12 | Why? |
| Glutathione | 3 | 2019 | 280 | 0.12 | Why? |
| Hospitals, Psychiatric | 1 | 2018 | 506 | 0.12 | Why? |
| Testis | 1 | 2017 | 566 | 0.12 | Why? |
| Sex Characteristics | 2 | 2017 | 1120 | 0.12 | Why? |
| Radiation Dosage | 1 | 2017 | 585 | 0.12 | Why? |
| Water | 1 | 2017 | 765 | 0.12 | Why? |
| Longitudinal Studies | 5 | 2018 | 9893 | 0.12 | Why? |
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2011 | 3 | 0.12 | Why? |
| Appendectomy | 1 | 2017 | 585 | 0.12 | Why? |
| Liver Failure, Acute | 1 | 2015 | 279 | 0.12 | Why? |
| Enzyme-Linked Immunosorbent Assay | 5 | 2020 | 7868 | 0.12 | Why? |
| Glycyrrhizic Acid | 1 | 2014 | 190 | 0.12 | Why? |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 526 | 0.12 | Why? |
| Organ Size | 3 | 2019 | 384 | 0.12 | Why? |
| Pyridines | 1 | 2018 | 680 | 0.12 | Why? |
| Hearing Loss | 1 | 2015 | 225 | 0.11 | Why? |
| Stroke Volume | 2 | 2019 | 2153 | 0.11 | Why? |
| Preoperative Period | 3 | 2017 | 271 | 0.11 | Why? |
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2011 | 11 | 0.11 | Why? |
| T-2 Toxin | 1 | 2010 | 2 | 0.11 | Why? |
| Receptor, Cannabinoid, CB1 | 1 | 2011 | 12 | 0.11 | Why? |
| Angiotensin II Type 1 Receptor Blockers | 1 | 2017 | 520 | 0.11 | Why? |
| Intellectual Disability | 1 | 2018 | 391 | 0.11 | Why? |
| Sequence Alignment | 1 | 2018 | 2109 | 0.11 | Why? |
| Ryanodine Receptor Calcium Release Channel | 1 | 2011 | 16 | 0.11 | Why? |
| Checklist | 1 | 2017 | 714 | 0.11 | Why? |
| Aging | 2 | 2018 | 3581 | 0.11 | Why? |
| Community Health Workers | 1 | 2017 | 468 | 0.11 | Why? |
| Lymphocytosis | 1 | 2012 | 122 | 0.11 | Why? |
| Vaccines, Subunit | 1 | 2018 | 1088 | 0.11 | Why? |
| Job Satisfaction | 1 | 2017 | 647 | 0.11 | Why? |
| Anticonvulsants | 1 | 2017 | 634 | 0.11 | Why? |
| Sequence Analysis, RNA | 2 | 2018 | 2290 | 0.11 | Why? |
| Cell Culture Techniques | 2 | 2019 | 704 | 0.11 | Why? |
| Stress, Psychological | 4 | 2019 | 10231 | 0.11 | Why? |
| Sequence Analysis, DNA | 2 | 2017 | 2830 | 0.11 | Why? |
| Tissue Plasminogen Activator | 1 | 2018 | 778 | 0.11 | Why? |
| Semen | 1 | 2017 | 550 | 0.11 | Why? |
| Purple Membrane | 1 | 2010 | 1 | 0.11 | Why? |
| Acetylcysteine | 3 | 2018 | 255 | 0.11 | Why? |
| Lymphocyte Count | 3 | 2017 | 4758 | 0.11 | Why? |
| Polysaccharides | 1 | 2019 | 854 | 0.11 | Why? |
| Coronary Vessels | 1 | 2018 | 914 | 0.11 | Why? |
| Haplotypes | 2 | 2012 | 853 | 0.11 | Why? |
| Cognition Disorders | 1 | 2016 | 574 | 0.11 | Why? |
| Acquired Immunodeficiency Syndrome | 1 | 2017 | 533 | 0.11 | Why? |
| Hydrogen-Ion Concentration | 4 | 2019 | 993 | 0.11 | Why? |
| Trace Elements | 1 | 2014 | 284 | 0.11 | Why? |
| Nanowires | 1 | 2010 | 25 | 0.11 | Why? |
| Algorithms | 2 | 2018 | 7346 | 0.11 | Why? |
| Endocannabinoids | 1 | 2011 | 56 | 0.11 | Why? |
| Adjuvants, Immunologic | 1 | 2020 | 1709 | 0.11 | Why? |
| Polyunsaturated Alkamides | 1 | 2011 | 40 | 0.11 | Why? |
| Cardiac Catheterization | 1 | 2018 | 882 | 0.11 | Why? |
| Pulmonary Artery | 1 | 2018 | 803 | 0.11 | Why? |
| Heart Rate | 2 | 2017 | 1527 | 0.11 | Why? |
| Linear Models | 4 | 2018 | 1914 | 0.11 | Why? |
| HLA Antigens | 1 | 2017 | 830 | 0.11 | Why? |
| Risk Assessment | 6 | 2020 | 25439 | 0.11 | Why? |
| Electric Power Supplies | 1 | 2010 | 30 | 0.11 | Why? |
| Dysbiosis | 1 | 2017 | 685 | 0.11 | Why? |
| Community Mental Health Centers | 1 | 2010 | 29 | 0.11 | Why? |
| Age Factors | 5 | 2018 | 21039 | 0.11 | Why? |
| Colonoscopy | 1 | 2017 | 738 | 0.11 | Why? |
| Health Services | 1 | 2017 | 765 | 0.11 | Why? |
| Calcium | 2 | 2018 | 708 | 0.11 | Why? |
| Rhinitis, Allergic | 1 | 2018 | 704 | 0.10 | Why? |
| Drug-Eluting Stents | 1 | 2017 | 562 | 0.10 | Why? |
| Electricity | 1 | 2010 | 68 | 0.10 | Why? |
| Selenium | 2 | 2017 | 412 | 0.10 | Why? |
| Prosthesis Design | 3 | 2018 | 594 | 0.10 | Why? |
| Psychiatric Status Rating Scales | 1 | 2017 | 1340 | 0.10 | Why? |
| Antibodies | 1 | 2017 | 846 | 0.10 | Why? |
| Statistics, Nonparametric | 3 | 2018 | 1008 | 0.10 | Why? |
| Social Networking | 1 | 2017 | 737 | 0.10 | Why? |
| Parotid Gland | 1 | 2010 | 53 | 0.10 | Why? |
| Subarachnoid Hemorrhage | 1 | 2016 | 611 | 0.10 | Why? |
| Shock, Septic | 1 | 2020 | 1313 | 0.10 | Why? |
| Air Pollutants | 2 | 2018 | 3110 | 0.10 | Why? |
| Models, Genetic | 1 | 2012 | 434 | 0.10 | Why? |
| Ether-A-Go-Go Potassium Channels | 1 | 2009 | 3 | 0.10 | Why? |
| High-Throughput Nucleotide Sequencing | 4 | 2017 | 3633 | 0.10 | Why? |
| Rituximab | 1 | 2018 | 1096 | 0.10 | Why? |
| Cations | 2 | 2020 | 77 | 0.10 | Why? |
| TRPV Cation Channels | 1 | 2011 | 88 | 0.10 | Why? |
| GTP-Binding Proteins | 1 | 2011 | 132 | 0.10 | Why? |
| Physician Executives | 1 | 2010 | 71 | 0.10 | Why? |
| Acetyltransferases | 1 | 2009 | 30 | 0.10 | Why? |
| Ebolavirus | 1 | 2017 | 834 | 0.10 | Why? |
| Heart Ventricles | 1 | 2019 | 1139 | 0.10 | Why? |
| Cohort Studies | 6 | 2018 | 36005 | 0.10 | Why? |
| Psychometrics | 1 | 2017 | 1269 | 0.10 | Why? |
| Endothelium, Vascular | 2 | 2019 | 1751 | 0.10 | Why? |
| Computer-Aided Design | 1 | 2010 | 94 | 0.10 | Why? |
| Corticosterone | 2 | 2019 | 18 | 0.10 | Why? |
| Virtual Reality | 1 | 2018 | 640 | 0.10 | Why? |
| Retinal Dehydrogenase | 2 | 2018 | 9 | 0.10 | Why? |
| Early Diagnosis | 1 | 2018 | 2443 | 0.10 | Why? |
| Crystallization | 1 | 2010 | 331 | 0.10 | Why? |
| Urban Population | 2 | 2017 | 2000 | 0.10 | Why? |
| Antibodies, Monoclonal, Humanized | 3 | 2017 | 9335 | 0.10 | Why? |
| Child, Preschool | 12 | 2019 | 36283 | 0.10 | Why? |
| Police | 1 | 2011 | 243 | 0.09 | Why? |
| Virion | 1 | 2017 | 1444 | 0.09 | Why? |
| Peptides | 2 | 2018 | 2513 | 0.09 | Why? |
| Vascular Diseases | 1 | 2018 | 846 | 0.09 | Why? |
| Cross-Sectional Studies | 6 | 2018 | 53120 | 0.09 | Why? |
| Acetylation | 2 | 2018 | 124 | 0.09 | Why? |
| Depressive Disorder, Major | 1 | 2018 | 852 | 0.09 | Why? |
| Immunity, Cellular | 2 | 2020 | 3614 | 0.09 | Why? |
| Multiple Myeloma | 1 | 2018 | 1064 | 0.09 | Why? |
| Patient Satisfaction | 2 | 2018 | 2517 | 0.09 | Why? |
| Bacterial Toxins | 1 | 2010 | 185 | 0.09 | Why? |
| DNA-Binding Proteins | 3 | 2018 | 469 | 0.09 | Why? |
| Antioxidant Response Elements | 2 | 2018 | 4 | 0.09 | Why? |
| Receptors, N-Methyl-D-Aspartate | 2 | 2019 | 81 | 0.09 | Why? |
| Nitric Oxide Synthase Type II | 2 | 2019 | 119 | 0.09 | Why? |
| Liver Function Tests | 1 | 2015 | 1325 | 0.09 | Why? |
| Matrix Metalloproteinase 3 | 2 | 2019 | 65 | 0.09 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2021 | 9659 | 0.09 | Why? |
| Social Behavior | 1 | 2017 | 882 | 0.09 | Why? |
| Sleep Apnea, Obstructive | 1 | 2017 | 668 | 0.09 | Why? |
| L-Lactate Dehydrogenase | 1 | 2017 | 1995 | 0.09 | Why? |
| Immunosuppressive Agents | 2 | 2017 | 6331 | 0.09 | Why? |
| ROC Curve | 5 | 2020 | 6024 | 0.09 | Why? |
| Tumor Burden | 1 | 2010 | 369 | 0.09 | Why? |
| Titanium | 1 | 2010 | 175 | 0.09 | Why? |
| Maze Learning | 2 | 2018 | 35 | 0.09 | Why? |
| Staphylococcal Infections | 1 | 2018 | 1099 | 0.09 | Why? |
| Hepatitis C, Chronic | 1 | 2017 | 973 | 0.09 | Why? |
| Zea mays | 2 | 2018 | 24 | 0.09 | Why? |
| Influenza, Human | 1 | 2013 | 10779 | 0.09 | Why? |
| Immune Evasion | 1 | 2018 | 2081 | 0.09 | Why? |
| Molecular Docking Simulation | 3 | 2019 | 6902 | 0.09 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 907 | 0.09 | Why? |
| Stress, Mechanical | 2 | 2019 | 143 | 0.09 | Why? |
| Cesarean Section | 1 | 2018 | 2089 | 0.09 | Why? |
| Reconstructive Surgical Procedures | 1 | 2018 | 860 | 0.09 | Why? |
| Sewage | 1 | 2013 | 591 | 0.09 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.09 | Why? |
| Leucovorin | 2 | 2018 | 70 | 0.09 | Why? |
| Genetic Markers | 1 | 2009 | 318 | 0.09 | Why? |
| Dopamine | 2 | 2019 | 123 | 0.09 | Why? |
| Bayes Theorem | 1 | 2017 | 3237 | 0.09 | Why? |
| Patient Positioning | 1 | 2018 | 1505 | 0.09 | Why? |
| Swimming | 2 | 2018 | 57 | 0.09 | Why? |
| Ventricular Function, Left | 1 | 2017 | 1555 | 0.09 | Why? |
| Phase Transition | 2 | 2017 | 25 | 0.09 | Why? |
| BCG Vaccine | 1 | 2018 | 1137 | 0.09 | Why? |
| Allantois | 1 | 2006 | 5 | 0.09 | Why? |
| Heart Arrest | 1 | 2018 | 1239 | 0.09 | Why? |
| Jurkat Cells | 2 | 2018 | 273 | 0.09 | Why? |
| Health Education | 1 | 2019 | 1539 | 0.09 | Why? |
| Metal Nanoparticles | 1 | 2015 | 771 | 0.09 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.08 | Why? |
| Creatinine | 3 | 2019 | 1443 | 0.08 | Why? |
| Echocardiography, Doppler, Color | 2 | 2018 | 114 | 0.08 | Why? |
| Colitis, Ulcerative | 1 | 2017 | 1037 | 0.08 | Why? |
| Healthy Volunteers | 3 | 2017 | 1444 | 0.08 | Why? |
| Methylation | 2 | 2018 | 332 | 0.08 | Why? |
| Pregnancy | 6 | 2018 | 23879 | 0.08 | Why? |
| Electrophoresis, Capillary | 1 | 2006 | 39 | 0.08 | Why? |
| Pulmonary Fibrosis | 1 | 2017 | 1068 | 0.08 | Why? |
| Green Fluorescent Proteins | 2 | 2018 | 450 | 0.08 | Why? |
| Matrix Metalloproteinases | 2 | 2017 | 131 | 0.08 | Why? |
| Headache | 1 | 2017 | 2257 | 0.08 | Why? |
| Virus Diseases | 2 | 2017 | 3779 | 0.08 | Why? |
| Forkhead Transcription Factors | 2 | 2018 | 231 | 0.08 | Why? |
| Graft Rejection | 1 | 2017 | 1766 | 0.08 | Why? |
| Kidney Transplantation | 2 | 2017 | 5397 | 0.08 | Why? |
| Physician-Patient Relations | 1 | 2017 | 1266 | 0.08 | Why? |
| Tumor Stem Cell Assay | 2 | 2018 | 12 | 0.08 | Why? |
| Plant Leaves | 2 | 2017 | 233 | 0.08 | Why? |
| Pregnancy Complications | 1 | 2018 | 1388 | 0.08 | Why? |
| Medicine, Chinese Traditional | 1 | 2019 | 2255 | 0.08 | Why? |
| Antibiotics, Antineoplastic | 2 | 2018 | 128 | 0.08 | Why? |
| Primary Cell Culture | 2 | 2018 | 501 | 0.08 | Why? |
| Semen Analysis | 2 | 2017 | 235 | 0.08 | Why? |
| Ubiquitination | 2 | 2018 | 343 | 0.08 | Why? |
| Virology | 1 | 2010 | 489 | 0.08 | Why? |
| Head and Neck Neoplasms | 1 | 2019 | 1568 | 0.08 | Why? |
| Motivation | 1 | 2017 | 1640 | 0.08 | Why? |
| Disabled Persons | 1 | 2017 | 1152 | 0.08 | Why? |
| Delayed-Action Preparations | 2 | 2019 | 291 | 0.08 | Why? |
| Models, Animal | 2 | 2020 | 788 | 0.08 | Why? |
| Gastrointestinal Microbiome | 1 | 2019 | 1961 | 0.08 | Why? |
| Alcohol Drinking | 1 | 2018 | 1663 | 0.08 | Why? |
| Conserved Sequence | 2 | 2019 | 751 | 0.08 | Why? |
| Prostate-Specific Antigen | 2 | 2017 | 213 | 0.08 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2017 | 1475 | 0.07 | Why? |
| Lymph Node Excision | 2 | 2018 | 362 | 0.07 | Why? |
| Endoplasmic Reticulum Stress | 2 | 2018 | 253 | 0.07 | Why? |
| Vero Cells | 2 | 2019 | 14117 | 0.07 | Why? |
| Psychotropic Drugs | 1 | 2010 | 396 | 0.07 | Why? |
| Tissue Inhibitor of Metalloproteinase-1 | 2 | 2018 | 33 | 0.07 | Why? |
| Comorbidity | 4 | 2018 | 34796 | 0.07 | Why? |
| Amino Acid Sequence | 4 | 2019 | 6049 | 0.07 | Why? |
| Amniotic Fluid | 1 | 2006 | 249 | 0.07 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.07 | Why? |
| Matrix Metalloproteinase 1 | 2 | 2018 | 60 | 0.07 | Why? |
| Protein Stability | 2 | 2018 | 756 | 0.07 | Why? |
| Hematologic Neoplasms | 1 | 2018 | 2105 | 0.07 | Why? |
| Diagnostic Imaging | 1 | 2013 | 1044 | 0.07 | Why? |
| Gene Expression Regulation, Enzymologic | 2 | 2019 | 436 | 0.07 | Why? |
| Antigens, CD34 | 2 | 2017 | 125 | 0.07 | Why? |
| Protein Interaction Domains and Motifs | 3 | 2019 | 2134 | 0.07 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.07 | Why? |
| Life Style | 1 | 2017 | 2708 | 0.07 | Why? |
| Tuberculosis, Pulmonary | 1 | 2015 | 1171 | 0.07 | Why? |
| Wounds and Injuries | 1 | 2017 | 1708 | 0.07 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.07 | Why? |
| Particulate Matter | 1 | 2017 | 3249 | 0.07 | Why? |
| African Americans | 2 | 2017 | 3363 | 0.07 | Why? |
| Lung Diseases | 1 | 2018 | 2361 | 0.07 | Why? |
| Workplace | 1 | 2017 | 2075 | 0.07 | Why? |
| Nitriles | 2 | 2020 | 1053 | 0.07 | Why? |
| Antibodies, Viral | 5 | 2020 | 51949 | 0.07 | Why? |
| Microscopy, Confocal | 2 | 2018 | 343 | 0.07 | Why? |
| Echocardiography, Transesophageal | 2 | 2018 | 447 | 0.07 | Why? |
| Vitamin D Deficiency | 1 | 2017 | 1782 | 0.07 | Why? |
| Lymphocyte Activation | 3 | 2018 | 2742 | 0.07 | Why? |
| Safety | 1 | 2011 | 1583 | 0.07 | Why? |
| Bacterial Infections | 1 | 2017 | 2229 | 0.06 | Why? |
| Electronic Health Records | 1 | 2017 | 3492 | 0.06 | Why? |
| Rectum | 2 | 2017 | 495 | 0.06 | Why? |
| Fluorescence | 2 | 2018 | 475 | 0.06 | Why? |
| Fatal Outcome | 1 | 2013 | 3438 | 0.06 | Why? |
| Thrombocytopenia | 1 | 2016 | 2093 | 0.06 | Why? |
| Biological Products | 1 | 2018 | 2331 | 0.06 | Why? |
| Homeostasis | 2 | 2017 | 582 | 0.06 | Why? |
| Markov Chains | 2 | 2017 | 502 | 0.06 | Why? |
| Molecular Sequence Data | 3 | 2014 | 3198 | 0.06 | Why? |
| Socioeconomic Factors | 2 | 2017 | 8495 | 0.06 | Why? |
| Glucocorticoids | 1 | 2018 | 4431 | 0.06 | Why? |
| Health Status | 2 | 2018 | 3259 | 0.06 | Why? |
| Mass Spectrometry | 2 | 2019 | 1165 | 0.06 | Why? |
| Vaccines, Synthetic | 3 | 2020 | 3231 | 0.06 | Why? |
| Immunophenotyping | 2 | 2018 | 1290 | 0.06 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
| Thiazoles | 2 | 2018 | 496 | 0.06 | Why? |
| Protein Conformation | 3 | 2018 | 4386 | 0.06 | Why? |
| Cellular Senescence | 2 | 2017 | 326 | 0.06 | Why? |
| Forecasting | 1 | 2017 | 4492 | 0.06 | Why? |
| Respiratory Tract Diseases | 1 | 2010 | 1061 | 0.06 | Why? |
| Patient Selection | 1 | 2017 | 4560 | 0.06 | Why? |
| Liver Transplantation | 1 | 2018 | 2864 | 0.06 | Why? |
| Air Pollution | 2 | 2019 | 3504 | 0.06 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.06 | Why? |
| Fever | 1 | 2018 | 7795 | 0.06 | Why? |
| Fatty Acids, Monounsaturated | 1 | 2020 | 42 | 0.06 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.06 | Why? |
| Genome, Viral | 3 | 2018 | 13157 | 0.05 | Why? |
| Intestines | 2 | 2017 | 817 | 0.05 | Why? |
| Immunologic Factors | 1 | 2017 | 4206 | 0.05 | Why? |
| Host-Pathogen Interactions | 2 | 2018 | 11041 | 0.05 | Why? |
| Software | 1 | 2012 | 2501 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Severity of Illness Index | 6 | 2019 | 48226 | 0.05 | Why? |
| Posterior Eye Segment | 1 | 2019 | 3 | 0.05 | Why? |
| Gonioscopy | 1 | 2019 | 10 | 0.05 | Why? |
| Crystallography, X-Ray | 2 | 2018 | 2689 | 0.05 | Why? |
| Sleep Wake Disorders | 1 | 2011 | 1463 | 0.05 | Why? |
| Hydrocarbons, Fluorinated | 1 | 2019 | 6 | 0.05 | Why? |
| gamma-Globulins | 1 | 2019 | 73 | 0.05 | Why? |
| Hepatocyte Nuclear Factor 3-gamma | 1 | 2019 | 2 | 0.05 | Why? |
| Asia | 2 | 2018 | 2399 | 0.05 | Why? |
| Kynurenic Acid | 1 | 2019 | 26 | 0.05 | Why? |
| Spinal Cord Neoplasms | 1 | 2019 | 18 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2020 | 5762 | 0.05 | Why? |
| Models, Biological | 4 | 2019 | 4907 | 0.05 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.05 | Why? |
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2019 | 15 | 0.05 | Why? |
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2019 | 23 | 0.05 | Why? |
| Chondroitin Sulfate Proteoglycans | 1 | 2018 | 2 | 0.05 | Why? |
| Chondrogenesis | 1 | 2019 | 19 | 0.05 | Why? |
| Cell Line, Transformed | 1 | 2019 | 87 | 0.05 | Why? |
| Tacrolimus Binding Proteins | 1 | 2018 | 15 | 0.05 | Why? |
| LDL-Receptor Related Proteins | 1 | 2018 | 2 | 0.05 | Why? |
| Time-Lapse Imaging | 1 | 2018 | 28 | 0.05 | Why? |
| Trinitrobenzenesulfonic Acid | 1 | 2018 | 12 | 0.05 | Why? |
| Frizzled Receptors | 1 | 2018 | 6 | 0.05 | Why? |
| Mesocolon | 1 | 2018 | 5 | 0.05 | Why? |
| Nasopharyngitis | 1 | 2018 | 16 | 0.05 | Why? |
| Complement Hemolytic Activity Assay | 1 | 2018 | 3 | 0.05 | Why? |
| Protein Prenylation | 1 | 2018 | 8 | 0.05 | Why? |
| Substantia Nigra | 1 | 2018 | 22 | 0.05 | Why? |
| Autonomic Pathways | 1 | 2018 | 8 | 0.05 | Why? |
| Small Ubiquitin-Related Modifier Proteins | 1 | 2018 | 11 | 0.05 | Why? |
| Laparoscopes | 1 | 2018 | 14 | 0.05 | Why? |
| Health Status Disparities | 1 | 2017 | 4072 | 0.05 | Why? |
| Genes, Lethal | 1 | 2018 | 1 | 0.05 | Why? |
| Nitrosative Stress | 1 | 2018 | 15 | 0.05 | Why? |
| Mental Status Schedule | 1 | 2018 | 34 | 0.05 | Why? |
| Reactive Nitrogen Species | 1 | 2018 | 36 | 0.05 | Why? |
| Swine, Miniature | 1 | 2018 | 33 | 0.05 | Why? |
| Cell Transdifferentiation | 1 | 2019 | 47 | 0.05 | Why? |
| Acetylglucosamine | 1 | 2018 | 14 | 0.05 | Why? |
| Neuronal Outgrowth | 1 | 2018 | 6 | 0.05 | Why? |
| Comet Assay | 1 | 2018 | 6 | 0.05 | Why? |
| Calcitonin Gene-Related Peptide | 1 | 2019 | 52 | 0.05 | Why? |
| STAT5 Transcription Factor | 1 | 2018 | 34 | 0.05 | Why? |
| Adenocarcinoma, Mucinous | 1 | 2018 | 27 | 0.05 | Why? |
| Carbenoxolone | 1 | 2018 | 1 | 0.05 | Why? |
| Meclofenamic Acid | 1 | 2018 | 1 | 0.05 | Why? |
| CRISPR-Cas Systems | 2 | 2019 | 1397 | 0.05 | Why? |
| Anemarrhena | 1 | 2018 | 2 | 0.05 | Why? |
| Cucurbita | 1 | 2018 | 5 | 0.05 | Why? |
| AlkB Homolog 5, RNA Demethylase | 1 | 2018 | 1 | 0.05 | Why? |
| Medicine, Tibetan Traditional | 1 | 2018 | 2 | 0.05 | Why? |
| Dichlorodiphenyl Dichloroethylene | 1 | 2018 | 4 | 0.05 | Why? |
| Ethylenes | 1 | 2018 | 12 | 0.05 | Why? |
| Activin Receptors, Type I | 1 | 2018 | 3 | 0.05 | Why? |
| Thiocarbamates | 1 | 2018 | 31 | 0.05 | Why? |
| Oxidopamine | 1 | 2018 | 9 | 0.05 | Why? |
| Bhutan | 1 | 2018 | 43 | 0.05 | Why? |
| Arsenites | 1 | 2018 | 15 | 0.05 | Why? |
| Medicine, Mongolian Traditional | 1 | 2018 | 10 | 0.05 | Why? |
| Wnt Proteins | 1 | 2018 | 38 | 0.05 | Why? |
| Lasers, Solid-State | 1 | 2019 | 56 | 0.05 | Why? |
| Tibet | 1 | 2018 | 80 | 0.05 | Why? |
| Dendritic Spines | 1 | 2018 | 3 | 0.05 | Why? |
| DNA Demethylation | 1 | 2018 | 3 | 0.05 | Why? |
| 5' Flanking Region | 1 | 2018 | 5 | 0.05 | Why? |
| Hydrocarbons, Chlorinated | 1 | 2018 | 11 | 0.05 | Why? |
| Endarterectomy, Carotid | 1 | 2019 | 78 | 0.05 | Why? |
| Capsules | 1 | 2019 | 140 | 0.05 | Why? |
| Mice, Knockout, ApoE | 1 | 2018 | 42 | 0.05 | Why? |
| Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 35 | 0.05 | Why? |
| Molecular Weight | 1 | 2019 | 249 | 0.05 | Why? |
| Chromosomes, Human, Pair 15 | 1 | 2018 | 13 | 0.05 | Why? |
| Genetic Drift | 1 | 2018 | 54 | 0.05 | Why? |
| Receptors, Transforming Growth Factor beta | 1 | 2018 | 20 | 0.05 | Why? |
| Occipital Lobe | 1 | 2018 | 26 | 0.05 | Why? |
| Antigens, Ly | 1 | 2018 | 17 | 0.05 | Why? |
| Spliceosomes | 1 | 2018 | 15 | 0.05 | Why? |
| Bile | 1 | 2018 | 56 | 0.05 | Why? |
| Carcinoma, Lobular | 1 | 2018 | 62 | 0.05 | Why? |
| Intestinal Elimination | 1 | 2017 | 3 | 0.05 | Why? |
| Microbial Sensitivity Tests | 2 | 2018 | 2886 | 0.05 | Why? |
| Annulus Fibrosus | 1 | 2018 | 3 | 0.05 | Why? |
| Sp7 Transcription Factor | 1 | 2017 | 3 | 0.05 | Why? |
| Cancer-Associated Fibroblasts | 1 | 2018 | 18 | 0.05 | Why? |
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 5 | 0.05 | Why? |
| GATA3 Transcription Factor | 1 | 2018 | 16 | 0.05 | Why? |
| Oxonic Acid | 1 | 2017 | 4 | 0.05 | Why? |
| Rhizosphere | 1 | 2018 | 8 | 0.05 | Why? |
| Abdominal Neoplasms | 1 | 2018 | 19 | 0.05 | Why? |
| Organic Anion Transport Protein 1 | 1 | 2017 | 7 | 0.05 | Why? |
| Caspase 1 | 1 | 2019 | 149 | 0.05 | Why? |
| Proteostasis | 1 | 2018 | 90 | 0.05 | Why? |
| Galactosylceramides | 1 | 2018 | 22 | 0.05 | Why? |
| Cimetidine | 1 | 2017 | 4 | 0.05 | Why? |
| Mitosis | 1 | 2018 | 43 | 0.05 | Why? |
| Androstadienes | 1 | 2018 | 27 | 0.05 | Why? |
| Microinjections | 1 | 2018 | 9 | 0.05 | Why? |
| Receptors, AMPA | 1 | 2018 | 17 | 0.05 | Why? |
| Phosphopyruvate Hydratase | 1 | 2018 | 47 | 0.05 | Why? |
| Vincristine | 1 | 2018 | 89 | 0.05 | Why? |
| Phenazines | 1 | 2018 | 12 | 0.05 | Why? |
| Mitochondria, Liver | 1 | 2018 | 18 | 0.05 | Why? |
| Isoenzymes | 1 | 2018 | 127 | 0.05 | Why? |
| Mice, Inbred NZB | 1 | 2017 | 4 | 0.05 | Why? |
| Dopamine Plasma Membrane Transport Proteins | 1 | 2018 | 37 | 0.05 | Why? |
| Azacitidine | 1 | 2018 | 42 | 0.05 | Why? |
| Serum | 1 | 2020 | 294 | 0.05 | Why? |
| Quorum Sensing | 1 | 2018 | 26 | 0.05 | Why? |
| Attitude of Health Personnel | 1 | 2017 | 4741 | 0.05 | Why? |
| Amino Acid Chloromethyl Ketones | 1 | 2018 | 62 | 0.05 | Why? |
| Dynamic Light Scattering | 1 | 2018 | 43 | 0.05 | Why? |
| Mastectomy, Segmental | 1 | 2018 | 124 | 0.05 | Why? |
| Cell Shape | 1 | 2017 | 57 | 0.05 | Why? |
| Plant Diseases | 1 | 2019 | 84 | 0.05 | Why? |
| Cocarcinogenesis | 1 | 2017 | 4 | 0.05 | Why? |
| Follicle Stimulating Hormone | 1 | 2018 | 73 | 0.05 | Why? |
| Intracellular Space | 1 | 2018 | 60 | 0.05 | Why? |
| Protein Aggregates | 1 | 2018 | 51 | 0.05 | Why? |
| Plant Stems | 1 | 2017 | 23 | 0.05 | Why? |
| Glycyrrhiza uralensis | 1 | 2017 | 3 | 0.05 | Why? |
| Occupational Exposure | 1 | 2017 | 4742 | 0.05 | Why? |
| Gallium Isotopes | 1 | 2017 | 42 | 0.05 | Why? |
| Serotonin | 1 | 2019 | 137 | 0.05 | Why? |
| Anhedonia | 1 | 2018 | 56 | 0.05 | Why? |
| Colforsin | 1 | 2017 | 4 | 0.05 | Why? |
| Nervous System Diseases | 1 | 2017 | 4092 | 0.05 | Why? |
| Polycyclic Aromatic Hydrocarbons | 1 | 2018 | 30 | 0.05 | Why? |
| Gene Duplication | 1 | 2017 | 31 | 0.05 | Why? |
| Glomerulonephritis, Membranoproliferative | 1 | 2017 | 30 | 0.05 | Why? |
| Hyalin | 1 | 2017 | 4 | 0.05 | Why? |
| Diabetes Mellitus | 2 | 2017 | 8207 | 0.05 | Why? |
| Tablets | 1 | 2019 | 219 | 0.05 | Why? |
| Chromatography, Thin Layer | 1 | 2018 | 37 | 0.05 | Why? |
| Organic Anion Transporters | 1 | 2017 | 40 | 0.05 | Why? |
| Glutathione Peroxidase | 1 | 2018 | 83 | 0.05 | Why? |
| Constriction, Pathologic | 1 | 2019 | 212 | 0.05 | Why? |
| Flowers | 1 | 2017 | 31 | 0.04 | Why? |
| Bone Regeneration | 1 | 2017 | 35 | 0.04 | Why? |
| Lipoylation | 1 | 2017 | 37 | 0.04 | Why? |
| Hydroxyethylrutoside | 1 | 2017 | 9 | 0.04 | Why? |
| Proto-Oncogene Proteins c-bcr | 1 | 2017 | 1 | 0.04 | Why? |
| Antibodies, Helminth | 1 | 2018 | 48 | 0.04 | Why? |
| Aquaporin 4 | 1 | 2018 | 69 | 0.04 | Why? |
| Fermentation | 1 | 2018 | 156 | 0.04 | Why? |
| Circular Dichroism | 1 | 2018 | 154 | 0.04 | Why? |
| Carbazoles | 1 | 2019 | 120 | 0.04 | Why? |
| Ocular Hypertension | 1 | 2018 | 35 | 0.04 | Why? |
| Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.04 | Why? |
| Mastocytosis, Systemic | 1 | 2018 | 44 | 0.04 | Why? |
| Phosphorus | 1 | 2018 | 80 | 0.04 | Why? |
| Receptors, Scavenger | 1 | 2017 | 24 | 0.04 | Why? |
| Phosphoproteins | 2 | 2019 | 4346 | 0.04 | Why? |
| Bicarbonates | 1 | 2017 | 33 | 0.04 | Why? |
| Mandibular Neoplasms | 1 | 2017 | 18 | 0.04 | Why? |
| Bile Acids and Salts | 1 | 2018 | 91 | 0.04 | Why? |
| Stereoisomerism | 1 | 2018 | 121 | 0.04 | Why? |
| Pleural Effusion, Malignant | 1 | 2018 | 37 | 0.04 | Why? |
| Transduction, Genetic | 1 | 2019 | 273 | 0.04 | Why? |
| Chromosome Deletion | 1 | 2018 | 62 | 0.04 | Why? |
| Antigens, Helminth | 1 | 2018 | 54 | 0.04 | Why? |
| Conversion to Open Surgery | 1 | 2017 | 35 | 0.04 | Why? |
| Lipid Peroxidation | 1 | 2018 | 114 | 0.04 | Why? |
| Epoxide Hydrolases | 1 | 2017 | 21 | 0.04 | Why? |
| Azoospermia | 1 | 2018 | 36 | 0.04 | Why? |
| Comparative Genomic Hybridization | 1 | 2017 | 33 | 0.04 | Why? |
| Protein Conformation, beta-Strand | 1 | 2019 | 414 | 0.04 | Why? |
| Patient Acceptance of Health Care | 1 | 2017 | 5002 | 0.04 | Why? |
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2017 | 1 | 0.04 | Why? |
| Theranostic Nanomedicine | 1 | 2018 | 143 | 0.04 | Why? |
| Anti-Anxiety Agents | 1 | 2019 | 139 | 0.04 | Why? |
| Hip Joint | 1 | 2018 | 59 | 0.04 | Why? |
| WNK Lysine-Deficient Protein Kinase 1 | 1 | 2017 | 1 | 0.04 | Why? |
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2018 | 92 | 0.04 | Why? |
| Synapses | 1 | 2018 | 83 | 0.04 | Why? |
| Founder Effect | 1 | 2018 | 92 | 0.04 | Why? |
| Actins | 1 | 2018 | 108 | 0.04 | Why? |
| Embryoid Bodies | 1 | 2017 | 9 | 0.04 | Why? |
| Chromones | 1 | 2017 | 42 | 0.04 | Why? |
| Mississippi | 1 | 2017 | 80 | 0.04 | Why? |
| Radiometry | 1 | 2018 | 136 | 0.04 | Why? |
| Paraffin Embedding | 1 | 2018 | 105 | 0.04 | Why? |
| Gallbladder | 1 | 2018 | 58 | 0.04 | Why? |
| Mice, 129 Strain | 1 | 2017 | 36 | 0.04 | Why? |
| Supine Position | 1 | 2018 | 158 | 0.04 | Why? |
| Oocyte Retrieval | 1 | 2017 | 44 | 0.04 | Why? |
| Thoracoscopy | 1 | 2018 | 113 | 0.04 | Why? |
| Tyrosine 3-Monooxygenase | 1 | 2017 | 32 | 0.04 | Why? |
| Castleman Disease | 1 | 2017 | 28 | 0.04 | Why? |
| Tetrazolium Salts | 1 | 2017 | 9 | 0.04 | Why? |
| Aniline Compounds | 1 | 2018 | 120 | 0.04 | Why? |
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2016 | 4 | 0.04 | Why? |
| Microscopy, Fluorescence | 1 | 2018 | 335 | 0.04 | Why? |
| Gallium Radioisotopes | 1 | 2017 | 90 | 0.04 | Why? |
| Hematuria | 1 | 2019 | 284 | 0.04 | Why? |
| United States | 4 | 2018 | 46150 | 0.04 | Why? |
| Phenytoin | 1 | 2017 | 17 | 0.04 | Why? |
| Gene Fusion | 1 | 2017 | 25 | 0.04 | Why? |
| Adenylate Kinase | 1 | 2016 | 13 | 0.04 | Why? |
| Immunomagnetic Separation | 1 | 2017 | 55 | 0.04 | Why? |
| Inhibitor of Apoptosis Proteins | 1 | 2017 | 21 | 0.04 | Why? |
| Durapatite | 1 | 2017 | 18 | 0.04 | Why? |
| Thymectomy | 1 | 2017 | 26 | 0.04 | Why? |
| Muscle, Smooth | 1 | 2017 | 67 | 0.04 | Why? |
| ATP Binding Cassette Transporter 1 | 1 | 2016 | 17 | 0.04 | Why? |
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2016 | 19 | 0.04 | Why? |
| Carbon Tetrachloride | 1 | 2017 | 27 | 0.04 | Why? |
| Cocaine | 1 | 2018 | 73 | 0.04 | Why? |
| Finite Element Analysis | 1 | 2017 | 27 | 0.04 | Why? |
| Pseudomonas | 1 | 2017 | 65 | 0.04 | Why? |
| Life Cycle Stages | 1 | 2018 | 162 | 0.04 | Why? |
| Thyroid Function Tests | 1 | 2018 | 200 | 0.04 | Why? |
| Free Radical Scavengers | 1 | 2018 | 82 | 0.04 | Why? |
| Scavenger Receptors, Class A | 1 | 2016 | 26 | 0.04 | Why? |
| Ovalbumin | 1 | 2017 | 84 | 0.04 | Why? |
| 5'-Nucleotidase | 1 | 2017 | 21 | 0.04 | Why? |
| Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 36 | 0.04 | Why? |
| CA-125 Antigen | 1 | 2017 | 34 | 0.04 | Why? |
| Stromal Cells | 1 | 2018 | 105 | 0.04 | Why? |
| Neutrophil Infiltration | 1 | 2018 | 201 | 0.04 | Why? |
| Parathyroid Hormone | 1 | 2017 | 98 | 0.04 | Why? |
| Anthracenes | 1 | 2016 | 28 | 0.04 | Why? |
| Soil | 1 | 2018 | 137 | 0.04 | Why? |
| Berberine | 1 | 2018 | 98 | 0.04 | Why? |
| PPAR gamma | 1 | 2018 | 102 | 0.04 | Why? |
| Protein Conformation, alpha-Helical | 1 | 2019 | 530 | 0.04 | Why? |
| Cobalt | 1 | 2016 | 33 | 0.04 | Why? |
| Menarche | 1 | 2017 | 21 | 0.04 | Why? |
| Injections, Intramuscular | 1 | 2020 | 800 | 0.04 | Why? |
| Epigenomics | 1 | 2018 | 139 | 0.04 | Why? |
| Saline Solution, Hypertonic | 1 | 2018 | 81 | 0.04 | Why? |
| Weight-Bearing | 1 | 2017 | 35 | 0.04 | Why? |
| Lentivirus | 1 | 2019 | 310 | 0.04 | Why? |
| Polyelectrolytes | 1 | 2017 | 47 | 0.04 | Why? |
| Surface Properties | 1 | 2019 | 448 | 0.04 | Why? |
| Sensory Receptor Cells | 1 | 2017 | 44 | 0.04 | Why? |
| Cytoplasm | 1 | 2018 | 304 | 0.04 | Why? |
| Anti-Mullerian Hormone | 1 | 2017 | 35 | 0.04 | Why? |
| CD36 Antigens | 1 | 2016 | 44 | 0.04 | Why? |
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 382 | 0.04 | Why? |
| Guideline Adherence | 1 | 2010 | 2309 | 0.04 | Why? |
| Blastocyst | 1 | 2017 | 65 | 0.04 | Why? |
| Fundus Oculi | 1 | 2018 | 237 | 0.04 | Why? |
| Interleukin-15 | 1 | 2018 | 169 | 0.04 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.04 | Why? |
| Calcitonin | 1 | 2019 | 201 | 0.04 | Why? |
| Perineum | 1 | 2017 | 70 | 0.04 | Why? |
| Peritoneum | 1 | 2016 | 54 | 0.04 | Why? |
| Cathepsin K | 1 | 2016 | 8 | 0.04 | Why? |
| Ephrin-B2 | 1 | 2016 | 3 | 0.04 | Why? |
| Receptor, Notch4 | 1 | 2016 | 35 | 0.04 | Why? |
| Scoliosis | 1 | 2017 | 45 | 0.04 | Why? |
| Mastocytosis | 1 | 2018 | 80 | 0.04 | Why? |
| Sperm Motility | 1 | 2017 | 106 | 0.04 | Why? |
| AMP-Activated Protein Kinases | 1 | 2017 | 93 | 0.04 | Why? |
| Magnetic Resonance Imaging, Interventional | 1 | 2016 | 38 | 0.04 | Why? |
| Transgenes | 1 | 2018 | 227 | 0.04 | Why? |
| Receptor, EphB4 | 1 | 2016 | 6 | 0.04 | Why? |
| Magnetic Resonance Angiography | 1 | 2018 | 282 | 0.04 | Why? |
| Creatine | 1 | 2017 | 66 | 0.04 | Why? |
| Enzymes | 1 | 2017 | 67 | 0.04 | Why? |
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2016 | 13 | 0.04 | Why? |
| Capecitabine | 1 | 2016 | 51 | 0.04 | Why? |
| Homozygote | 1 | 2018 | 230 | 0.04 | Why? |
| Half-Life | 1 | 2017 | 298 | 0.04 | Why? |
| Endometrium | 1 | 2017 | 68 | 0.04 | Why? |
| Menstruation | 1 | 2017 | 81 | 0.04 | Why? |
| Synovial Fluid | 1 | 2017 | 64 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Viruses | 1 | 2010 | 2238 | 0.04 | Why? |
| Oocytes | 1 | 2017 | 86 | 0.04 | Why? |
| Interleukin-33 | 1 | 2018 | 120 | 0.04 | Why? |
| Uterus | 1 | 2017 | 98 | 0.04 | Why? |
| Radiotherapy Dosage | 1 | 2018 | 428 | 0.04 | Why? |
| Vascular Cell Adhesion Molecule-1 | 1 | 2016 | 121 | 0.04 | Why? |
| Thoracic Surgery, Video-Assisted | 1 | 2017 | 97 | 0.04 | Why? |
| Osteoprotegerin | 1 | 2016 | 32 | 0.04 | Why? |
| Audiovisual Aids | 1 | 2018 | 138 | 0.04 | Why? |
| Vascular Patency | 1 | 2016 | 96 | 0.04 | Why? |
| Proton Magnetic Resonance Spectroscopy | 1 | 2017 | 159 | 0.04 | Why? |
| Lactones | 1 | 2017 | 62 | 0.04 | Why? |
| Biological Transport | 1 | 2017 | 290 | 0.04 | Why? |
| Toll-Like Receptor 2 | 1 | 2018 | 198 | 0.04 | Why? |
| Calibration | 1 | 2017 | 307 | 0.04 | Why? |
| Retinal Pigment Epithelium | 1 | 2016 | 62 | 0.04 | Why? |
| Injections, Intravenous | 1 | 2017 | 381 | 0.04 | Why? |
| Tissue Distribution | 1 | 2018 | 483 | 0.04 | Why? |
| Blood Gas Monitoring, Transcutaneous | 1 | 2016 | 52 | 0.04 | Why? |
| Rest | 1 | 2017 | 188 | 0.04 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2017 | 325 | 0.04 | Why? |
| Polyesters | 1 | 2017 | 94 | 0.04 | Why? |
| Albumins | 1 | 2019 | 324 | 0.04 | Why? |
| Dimerization | 1 | 2018 | 475 | 0.04 | Why? |
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2016 | 75 | 0.04 | Why? |
| Immunoglobulin G | 2 | 2017 | 21571 | 0.04 | Why? |
| Gene Library | 1 | 2017 | 234 | 0.04 | Why? |
| Sierra Leone | 1 | 2017 | 267 | 0.04 | Why? |
| Drug Compounding | 1 | 2019 | 386 | 0.04 | Why? |
| Connexin 26 | 1 | 2015 | 9 | 0.04 | Why? |
| Gene Ontology | 1 | 2018 | 391 | 0.04 | Why? |
| Dose-Response Relationship, Immunologic | 1 | 2018 | 593 | 0.04 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2019 | 635 | 0.04 | Why? |
| Dioxygenases | 1 | 2016 | 40 | 0.04 | Why? |
| Alemtuzumab | 1 | 2017 | 121 | 0.04 | Why? |
| Thymus Gland | 1 | 2017 | 126 | 0.04 | Why? |
| 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 1 | 2015 | 1 | 0.04 | Why? |
| Vasospasm, Intracranial | 1 | 2016 | 50 | 0.04 | Why? |
| Biological Availability | 1 | 2017 | 388 | 0.04 | Why? |
| Hydroxyeicosatetraenoic Acids | 1 | 2015 | 5 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Cell-Free System | 1 | 2015 | 23 | 0.04 | Why? |
| Cyclophosphamide | 1 | 2018 | 387 | 0.04 | Why? |
| Sodium | 1 | 2018 | 309 | 0.04 | Why? |
| Myocytes, Smooth Muscle | 1 | 2017 | 127 | 0.04 | Why? |
| Staurosporine | 1 | 2015 | 5 | 0.04 | Why? |
| Azathioprine | 1 | 2017 | 161 | 0.04 | Why? |
| Linoleic Acids | 1 | 2015 | 51 | 0.04 | Why? |
| Adsorption | 1 | 2017 | 261 | 0.04 | Why? |
| Proline | 1 | 2018 | 345 | 0.04 | Why? |
| Medically Uninsured | 1 | 2018 | 237 | 0.04 | Why? |
| Sequence Homology, Nucleic Acid | 1 | 2017 | 368 | 0.04 | Why? |
| Single-Blind Method | 1 | 2020 | 1283 | 0.04 | Why? |
| Electrodes | 1 | 2017 | 203 | 0.04 | Why? |
| Cardiotonic Agents | 1 | 2019 | 418 | 0.04 | Why? |
| Ultrasonography, Doppler, Transcranial | 1 | 2017 | 143 | 0.04 | Why? |
| Cryoglobulinemia | 1 | 2017 | 144 | 0.04 | Why? |
| Sus scrofa | 1 | 2017 | 205 | 0.04 | Why? |
| Drug Resistance | 1 | 2018 | 395 | 0.04 | Why? |
| Publication Bias | 1 | 2017 | 241 | 0.04 | Why? |
| Proteinuria | 1 | 2019 | 474 | 0.04 | Why? |
| Interferon-gamma Release Tests | 1 | 2018 | 253 | 0.04 | Why? |
| HLA-B Antigens | 1 | 2017 | 166 | 0.04 | Why? |
| Antibodies, Antinuclear | 1 | 2017 | 234 | 0.04 | Why? |
| Altitude Sickness | 1 | 2017 | 95 | 0.04 | Why? |
| Models, Anatomic | 1 | 2017 | 191 | 0.04 | Why? |
| Microscopy, Electron, Transmission | 1 | 2018 | 605 | 0.04 | Why? |
| Hearing Tests | 1 | 2015 | 76 | 0.04 | Why? |
| Protein Subunits | 1 | 2018 | 755 | 0.04 | Why? |
| Fascia | 1 | 2015 | 11 | 0.04 | Why? |
| Preliminary Data | 1 | 2017 | 457 | 0.04 | Why? |
| Oxides | 1 | 2016 | 77 | 0.04 | Why? |
| Whole Exome Sequencing | 1 | 2018 | 437 | 0.04 | Why? |
| Protein Folding | 1 | 2017 | 270 | 0.04 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2017 | 640 | 0.04 | Why? |
| Immunoglobulin E | 1 | 2019 | 557 | 0.04 | Why? |
| X-Ray Diffraction | 1 | 2016 | 249 | 0.04 | Why? |
| Angiography | 1 | 2016 | 301 | 0.04 | Why? |
| P-Selectin | 1 | 2016 | 224 | 0.04 | Why? |
| Cell-Free Nucleic Acids | 1 | 2018 | 271 | 0.04 | Why? |
| Hemolysis | 1 | 2018 | 283 | 0.04 | Why? |
| International Agencies | 1 | 2016 | 202 | 0.04 | Why? |
| Necrosis | 1 | 2018 | 532 | 0.04 | Why? |
| Microsurgery | 1 | 2017 | 166 | 0.04 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2018 | 219 | 0.04 | Why? |
| Arterial Pressure | 1 | 2017 | 208 | 0.04 | Why? |
| Polycomb-Group Proteins | 1 | 2014 | 8 | 0.04 | Why? |
| Cluster Analysis | 2 | 2014 | 3001 | 0.04 | Why? |
| 5' Untranslated Regions | 1 | 2018 | 375 | 0.04 | Why? |
| Ligases | 1 | 2014 | 36 | 0.04 | Why? |
| Hematopoietic Stem Cells | 1 | 2018 | 321 | 0.04 | Why? |
| Magnetic Phenomena | 1 | 2015 | 148 | 0.04 | Why? |
| Cyclin-Dependent Kinase 4 | 1 | 2014 | 44 | 0.04 | Why? |
| Antigen Presentation | 1 | 2018 | 524 | 0.04 | Why? |
| Ulcer | 1 | 2016 | 128 | 0.04 | Why? |
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2017 | 237 | 0.04 | Why? |
| Nociception | 1 | 2014 | 25 | 0.03 | Why? |
| Population Dynamics | 1 | 2018 | 378 | 0.03 | Why? |
| Observer Variation | 1 | 2017 | 622 | 0.03 | Why? |
| Capsaicin | 1 | 2014 | 19 | 0.03 | Why? |
| Mutagenesis | 1 | 2017 | 394 | 0.03 | Why? |
| Spinal Nerves | 1 | 2014 | 18 | 0.03 | Why? |
| Fluorescein Angiography | 1 | 2018 | 426 | 0.03 | Why? |
| RNA, Antisense | 1 | 2014 | 39 | 0.03 | Why? |
| Kidney Function Tests | 1 | 2016 | 520 | 0.03 | Why? |
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 317 | 0.03 | Why? |
| Adenoma | 1 | 2017 | 215 | 0.03 | Why? |
| Anxiety | 2 | 2019 | 17311 | 0.03 | Why? |
| Mast Cells | 1 | 2018 | 370 | 0.03 | Why? |
| Potassium | 1 | 2017 | 325 | 0.03 | Why? |
| Herpes Simplex | 1 | 2017 | 272 | 0.03 | Why? |
| Th2 Cells | 1 | 2018 | 680 | 0.03 | Why? |
| Bacterial Physiological Phenomena | 1 | 2013 | 31 | 0.03 | Why? |
| Phylogeography | 1 | 2018 | 824 | 0.03 | Why? |
| Hospitals, High-Volume | 1 | 2018 | 688 | 0.03 | Why? |
| Ligation | 1 | 2014 | 84 | 0.03 | Why? |
| Adolescent Health | 1 | 2017 | 227 | 0.03 | Why? |
| Patient Outcome Assessment | 1 | 2018 | 707 | 0.03 | Why? |
| Protective Agents | 1 | 2017 | 250 | 0.03 | Why? |
| Salvage Therapy | 1 | 2016 | 417 | 0.03 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.03 | Why? |
| Vasodilator Agents | 1 | 2017 | 344 | 0.03 | Why? |
| Africa, Western | 1 | 2015 | 363 | 0.03 | Why? |
| Induced Pluripotent Stem Cells | 1 | 2019 | 584 | 0.03 | Why? |
| Point Mutation | 1 | 2017 | 481 | 0.03 | Why? |
| Medical Records | 1 | 2016 | 513 | 0.03 | Why? |
| Nepal | 1 | 2018 | 1004 | 0.03 | Why? |
| Critical Care | 1 | 2017 | 14081 | 0.03 | Why? |
| Hyaluronic Acid | 1 | 2015 | 168 | 0.03 | Why? |
| Trachea | 1 | 2018 | 894 | 0.03 | Why? |
| HapMap Project | 1 | 2012 | 6 | 0.03 | Why? |
| Viral Regulatory and Accessory Proteins | 1 | 2019 | 482 | 0.03 | Why? |
| Knowledge | 1 | 2018 | 452 | 0.03 | Why? |
| Respiration, Artificial | 1 | 2019 | 22116 | 0.03 | Why? |
| Anaerobiosis | 1 | 2013 | 146 | 0.03 | Why? |
| Infant | 4 | 2018 | 30274 | 0.03 | Why? |
| Protein Biosynthesis | 1 | 2018 | 653 | 0.03 | Why? |
| RNA, Ribosomal, 16S | 1 | 2017 | 793 | 0.03 | Why? |
| bcl-2-Associated X Protein | 1 | 2012 | 45 | 0.03 | Why? |
| Ultrasonography, Doppler | 1 | 2016 | 406 | 0.03 | Why? |
| Lower Extremity | 1 | 2018 | 593 | 0.03 | Why? |
| Pregnancy Outcome | 2 | 2018 | 3803 | 0.03 | Why? |
| Caco-2 Cells | 1 | 2017 | 1236 | 0.03 | Why? |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 314 | 0.03 | Why? |
| Splenomegaly | 1 | 2012 | 43 | 0.03 | Why? |
| Nucleic Acid Conformation | 1 | 2017 | 621 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Retina | 1 | 2018 | 424 | 0.03 | Why? |
| Antibody Affinity | 1 | 2018 | 1078 | 0.03 | Why? |
| Focus Groups | 1 | 2017 | 811 | 0.03 | Why? |
| Information Storage and Retrieval | 1 | 2019 | 644 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2020 | 37182 | 0.03 | Why? |
| Colony-Forming Units Assay | 1 | 2012 | 4 | 0.03 | Why? |
| Pseudomonas aeruginosa | 1 | 2018 | 652 | 0.03 | Why? |
| Radiopharmaceuticals | 1 | 2018 | 763 | 0.03 | Why? |
| Germ-Line Mutation | 1 | 2012 | 86 | 0.03 | Why? |
| Prenatal Diagnosis | 1 | 2015 | 345 | 0.03 | Why? |
| Oxygen Consumption | 1 | 2017 | 711 | 0.03 | Why? |
| Risk | 2 | 2017 | 5288 | 0.03 | Why? |
| Positron-Emission Tomography | 1 | 2018 | 802 | 0.03 | Why? |
| Indians, North American | 1 | 2015 | 195 | 0.03 | Why? |
| Immunoblotting | 1 | 2012 | 180 | 0.03 | Why? |
| Focal Adhesions | 1 | 2011 | 10 | 0.03 | Why? |
| CD4 Lymphocyte Count | 1 | 2017 | 1517 | 0.03 | Why? |
| Linkage Disequilibrium | 1 | 2012 | 191 | 0.03 | Why? |
| Task Performance and Analysis | 1 | 2011 | 68 | 0.03 | Why? |
| Principal Component Analysis | 1 | 2014 | 689 | 0.03 | Why? |
| Office Visits | 1 | 2017 | 489 | 0.03 | Why? |
| Nucleic Acids | 1 | 2017 | 435 | 0.03 | Why? |
| Fertilization in Vitro | 1 | 2015 | 330 | 0.03 | Why? |
| Patient Reported Outcome Measures | 1 | 2018 | 912 | 0.03 | Why? |
| Colon | 1 | 2017 | 669 | 0.03 | Why? |
| Neurodegenerative Diseases | 1 | 2018 | 469 | 0.03 | Why? |
| Ubiquitin-Protein Ligases | 1 | 2014 | 249 | 0.03 | Why? |
| Diabetic Retinopathy | 1 | 2016 | 347 | 0.03 | Why? |
| Ligands | 1 | 2017 | 1300 | 0.03 | Why? |
| Counseling | 1 | 2018 | 747 | 0.03 | Why? |
| Seasons | 2 | 2017 | 4071 | 0.03 | Why? |
| HSP70 Heat-Shock Proteins | 1 | 2012 | 113 | 0.03 | Why? |
| Particle Size | 1 | 2017 | 1052 | 0.03 | Why? |
| Exercise Test | 1 | 2018 | 911 | 0.03 | Why? |
| alpha-Macroglobulins | 1 | 2010 | 17 | 0.03 | Why? |
| User-Computer Interface | 1 | 2018 | 1068 | 0.03 | Why? |
| Fluorescein-5-isothiocyanate | 1 | 2010 | 15 | 0.03 | Why? |
| Hemoglobins | 1 | 2017 | 958 | 0.03 | Why? |
| Population Density | 1 | 2017 | 694 | 0.03 | Why? |
| Ascorbic Acid | 1 | 2017 | 676 | 0.03 | Why? |
| Interferon-beta | 1 | 2017 | 979 | 0.03 | Why? |
| Bacteriorhodopsins | 1 | 2010 | 1 | 0.03 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 449 | 0.03 | Why? |
| Plants, Medicinal | 1 | 2017 | 622 | 0.03 | Why? |
| Signal Processing, Computer-Assisted | 1 | 2013 | 193 | 0.03 | Why? |
| Cricetinae | 1 | 2019 | 3344 | 0.03 | Why? |
| Cytomegalovirus Infections | 1 | 2017 | 667 | 0.03 | Why? |
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2010 | 45 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Practice Guidelines as Topic | 2 | 2017 | 15421 | 0.03 | Why? |
| Indonesia | 1 | 2015 | 1022 | 0.03 | Why? |
| Spatio-Temporal Analysis | 1 | 2017 | 1182 | 0.03 | Why? |
| Diagnostic Errors | 1 | 2017 | 865 | 0.03 | Why? |
| Cambodia | 1 | 2010 | 190 | 0.03 | Why? |
| Neuroimaging | 1 | 2018 | 1106 | 0.03 | Why? |
| Biogenic Polyamines | 1 | 2009 | 1 | 0.03 | Why? |
| Cyclin A | 1 | 2009 | 6 | 0.03 | Why? |
| S Phase | 1 | 2009 | 12 | 0.03 | Why? |
| Automation | 1 | 2013 | 429 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2018 | 9091 | 0.03 | Why? |
| E2F1 Transcription Factor | 1 | 2009 | 11 | 0.03 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2018 | 1153 | 0.03 | Why? |
| Transistors, Electronic | 1 | 2010 | 48 | 0.03 | Why? |
| Serous Membrane | 1 | 2009 | 3 | 0.03 | Why? |
| Colombia | 1 | 2015 | 1241 | 0.03 | Why? |
| Anemia | 1 | 2017 | 789 | 0.03 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.03 | Why? |
| Sulfonamides | 1 | 2019 | 1294 | 0.03 | Why? |
| Macaca mulatta | 1 | 2020 | 3716 | 0.03 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2018 | 1439 | 0.03 | Why? |
| Family Health | 1 | 2015 | 731 | 0.03 | Why? |
| Integrin alpha4beta1 | 1 | 2009 | 5 | 0.03 | Why? |
| Biodiversity | 1 | 2013 | 546 | 0.03 | Why? |
| Respiratory Tract Infections | 1 | 2011 | 6817 | 0.02 | Why? |
| Lymphocyte Function-Associated Antigen-1 | 1 | 2009 | 19 | 0.02 | Why? |
| Vietnam | 1 | 2015 | 1665 | 0.02 | Why? |
| Virus Internalization | 2 | 2019 | 7921 | 0.02 | Why? |
| Intestinal Mucosa | 1 | 2017 | 1046 | 0.02 | Why? |
| Antibody-Dependent Cell Cytotoxicity | 1 | 2011 | 349 | 0.02 | Why? |
| Area Under Curve | 1 | 2017 | 2564 | 0.02 | Why? |
| Immunity, Innate | 2 | 2018 | 6570 | 0.02 | Why? |
| Interferon-alpha | 1 | 2017 | 1442 | 0.02 | Why? |
| Pneumothorax | 1 | 2018 | 758 | 0.02 | Why? |
| Ecosystem | 1 | 2014 | 776 | 0.02 | Why? |
| Health Expenditures | 1 | 2017 | 904 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Observational Studies as Topic | 1 | 2017 | 1887 | 0.02 | Why? |
| Child Psychiatry | 1 | 2010 | 107 | 0.02 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.02 | Why? |
| Antipsychotic Agents | 1 | 2017 | 887 | 0.02 | Why? |
| Models, Theoretical | 2 | 2018 | 6659 | 0.02 | Why? |
| Trauma Centers | 1 | 2017 | 1195 | 0.02 | Why? |
| Delivery, Obstetric | 1 | 2018 | 1292 | 0.02 | Why? |
| Gastric Mucosa | 1 | 2009 | 141 | 0.02 | Why? |
| Propensity Score | 1 | 2017 | 2690 | 0.02 | Why? |
| Depressive Disorder | 1 | 2019 | 1236 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 2309 | 0.02 | Why? |
| Virus Inactivation | 1 | 2017 | 1139 | 0.02 | Why? |
| Income | 1 | 2017 | 1564 | 0.02 | Why? |
| Crohn Disease | 1 | 2017 | 959 | 0.02 | Why? |
| Complement System Proteins | 1 | 2011 | 380 | 0.02 | Why? |
| Blood Transfusion | 1 | 2017 | 1399 | 0.02 | Why? |
| Single-Cell Analysis | 1 | 2018 | 2450 | 0.02 | Why? |
| Dexamethasone | 1 | 2018 | 2055 | 0.02 | Why? |
| Protein Domains | 1 | 2020 | 6563 | 0.02 | Why? |
| North America | 1 | 2011 | 1400 | 0.02 | Why? |
| Prone Position | 1 | 2018 | 1861 | 0.02 | Why? |
| Myocardium | 1 | 2019 | 2323 | 0.02 | Why? |
| Mexico | 1 | 2015 | 2787 | 0.02 | Why? |
| Chick Embryo | 1 | 2006 | 249 | 0.02 | Why? |
| Residence Characteristics | 1 | 2017 | 1927 | 0.02 | Why? |
| Hypertension | 2 | 2018 | 8895 | 0.02 | Why? |
| Poverty | 1 | 2018 | 2302 | 0.02 | Why? |
| Specific Pathogen-Free Organisms | 1 | 2006 | 358 | 0.02 | Why? |
| Anxiety Disorders | 1 | 2019 | 2290 | 0.02 | Why? |
| Incidence | 2 | 2017 | 25622 | 0.02 | Why? |
| Epilepsy | 1 | 2018 | 1401 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.02 | Why? |
| Dietary Supplements | 1 | 2017 | 2251 | 0.02 | Why? |
| Acute Disease | 1 | 2018 | 6029 | 0.02 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2018 | 1876 | 0.02 | Why? |
| Survivors | 1 | 2017 | 2619 | 0.02 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.02 | Why? |
| Dementia | 1 | 2018 | 1861 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2017 | 4155 | 0.02 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.02 | Why? |
| Antibodies, Neutralizing | 2 | 2020 | 25288 | 0.02 | Why? |
| Chemokines | 1 | 2009 | 1095 | 0.02 | Why? |
| Iran | 1 | 2015 | 5467 | 0.01 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4545 | 0.01 | Why? |
| Hot Temperature | 1 | 2010 | 1299 | 0.01 | Why? |
| Health Services Needs and Demand | 1 | 2017 | 3419 | 0.01 | Why? |
| Seroepidemiologic Studies | 1 | 2017 | 10017 | 0.01 | Why? |
| Coronavirus | 1 | 2011 | 18339 | 0.01 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.01 | Why? |
| Health Care Surveys | 1 | 2010 | 2942 | 0.01 | Why? |
| Internet | 1 | 2019 | 6204 | 0.01 | Why? |
| Inflammatory Bowel Diseases | 1 | 2017 | 3209 | 0.01 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.01 | Why? |
| Models, Statistical | 1 | 2016 | 5312 | 0.01 | Why? |
| Ambulatory Care Facilities | 1 | 2010 | 2063 | 0.01 | Why? |
| Infectious bronchitis virus | 1 | 2006 | 856 | 0.01 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.01 | Why? |
| Heart Failure | 1 | 2019 | 6638 | 0.01 | Why? |
| India | 1 | 2015 | 11875 | 0.01 | Why? |
| Occupational Health | 1 | 2011 | 3965 | 0.01 | Why? |
| Pediatrics | 1 | 2010 | 2969 | 0.01 | Why? |
| Critical Illness | 1 | 2017 | 17281 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Health Services Accessibility | 1 | 2017 | 10697 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2017 | 27595 | 0.01 | Why? |
| Mental Health | 1 | 2010 | 15770 | 0.00 | Why? |